1. University of Copenhagen
2. Technical University of Denmark (DTU)
3. Aarhus University
4. University of Southern Denmark (SDU)
5. Aalborg University
6. Roskilde University
7. Copenhagen Business School (CBS)
8. University of Aalborg (additional campus focus)
9. IT University of Copenhagen
10. VIA University College
11. Aarhus School of Architecture
12. Copenhagen School of Design and Technology (KEA)
13. University College South Denmark
14. University College of Northern Denmark
15. Business Academy Aarhus
16. Zealand Academy of Technologies and Business
17. University College Lillebaelt
18. KEA – Copenhagen School of Design and Technology
19. The Royal Danish Academy of Fine Arts, Schools of Architecture, Design and Conservation
20. The Royal Danish Academy of Music
21. University College Absalon
22. University College Sealand
23. Dania Academy of Higher Education
24. University College of Jutland (merged into others)
25. Metropolitan University College (now part of Copenhagen Business Academy)
26. Niels Brock Copenhagen Business College
27. IBA School of Business and Society (now part of University College of Northern Denmark)
28. Danish School of Media and Journalism
29. Design School Kolding
30. Danish Technological Institute (affiliated education programs)

1. University of Copenhagen

📞 Phone & WhatsApp:
📌 +44 7883 646080
📌 +44 7585727913

📌 +44 7593866345

📧 Email:
📌 info@visituniversities.com
📌 oxbridge2020@gmail.com

———————–

📢 Contact Us – Get Started Today!

📍 Head Office:
🏢 Dane’s Yard, Sugar House Island, Stratford, London E15, United Kingdom

📍 International Branches:
📌 India – 201, A Building, Kangan, NIBM Road, Pune City
📌 USA – 2461 W Bulson Rd, Mount Vernon, Washington (WA), 98274

📧 Email:
📌 info@visituniversities.com
📌 oxbridge2020@gmail.com

📞 WhatsApp & Phone Support:
📌 +44 7883 646080
📌 +44 7585727913

📌 +44 7593866345

 

📩 Direct CEO Contact:
📌 graywolf650@gmail.com

🌍 Website: www.visituniversities.com

Overview and Institutional Profile

The University of Copenhagen (UCPH), ranked first in Denmark and among the top 100 globally by the Times Higher Education World University Rankings 2025, is Denmark’s oldest and largest university, founded in 1479. Its Faculty of Health and Medical Sciences, established in 1829, is a leading hub for medical education and research, affiliated with Rigshospitalet (Copenhagen University Hospital), the country’s primary tertiary care center. Rigshospitalet handles over 50,000 oncology patients annually, specializing in precision oncology, immunotherapy, and rare cancers through centers like the Danish Cancer Society Research Centre and the Finsen Center for Radiation Oncology. UCPH’s oncology research ecosystem includes over 200 groups focusing on translational trials, genomic sequencing, and AI in diagnostics, with €100 million in annual funding from the Novo Nordisk Foundation, Horizon Europe, and the Danish Cancer Society. The university coordinates 150+ EU projects and publishes 2,000+ oncology articles yearly in journals like The Lancet Oncology. As a teaching hospital, it trains 1,500 medical students and 300 specialists annually, emphasizing evidence-based care and innovation. The Visiting Fellowship for Physicians at UCPH, primarily the ESMO-FECC Clinical Research Fellowship (adapted for Denmark), offers 3–6 month immersions for early-career oncologists, embedding fellows in Rigshospitalet’s Department of Oncology for hands-on training in clinical trials and multidisciplinary care. Launched in 2005, over 50 fellows have participated, with 80% advancing to leadership roles in European oncology, aligning with Denmark’s National Cancer Plan for equitable access and research excellence.

Eligibility Requirements

The ESMO-FECC Clinical Research Fellowship at UCPH targets physicians aged 40 or younger at application. Applicants must hold an MD or equivalent, with at least two years of postgraduate training in medical oncology, radiation oncology, or hematology; final-year residents are eligible if certification is obtained before start. Active ESMO membership is mandatory, alongside demonstrated research commitment via one first-author PubMed-indexed publication or sub-investigator role in a trial. English proficiency (IELTS ≥7.0 or equivalent) is required; Danish (B1 level) recommended for patient interactions at Rigshospitalet. Candidates must maintain affiliation with a European home institution and arrange leave. GCP certification (≤3 years) is prerequisite. Proposals aligned with UCPH’s pillars—immunotherapy resistance, genomic trials, or AI diagnostics—are prioritized. Exclusions include prior ESMO funding >€15,000 or concurrent grants. Diversity targets 35% female and global south applicants; Rigshospitalet experience enhances competitiveness.

Application Cycle and Deadlines (2025–2026)

As of November 22, 2025, the primary 2025 cycle has closed (opened March 1, 2025; deadline May 29, 2025), with notifications by August 15, 2025, and starts from October 1, 2025, to April 1, 2026. For 2026 intake, a supplementary call opens December 1, 2025, closing January 31, 2026, via ESMO portal (esmo.org). Results by April 15, 2026; flexible starts June 1–December 1, 2026. The full 2026–2027 cycle reopens March 1, 2026, closing May 29, 2026. UCPH/Rigshospitalet allocates 2–3 slots; pre-endorsement from a host mentor (e.g., Prof. Christina H. Ruhlmann in oncology) by December 15, 2025. Acceptance: 20–25%, by ESMO Leadership Development Committee.

Required Documents (all in English)

Via ESMO portal: (1) CV (4 pages, ESMO template, with publications/trials); (2) Proposal (1,800–2,500 words: hypothesis, methodology, UCPH resources (e.g., Finsen Center), timeline, ethics); (3) Motivation letter (1,000 words: goals, UCPH fit, dissemination); (4) Two recommendations (clinical/research); (5) Host acceptance from Rigshospitalet faculty; (6) ESMO membership, GCP, language proofs; (7) Diploma, training certificates, employment verification; (8) GDPR-compliant data plan. Incomplete submissions rejected.

Funding and Practical Conditions

Funding: €4,000/month stipend (tax-exempt; €4,500 family); €1,200 travel; €2,500 bench fee. 3–6 months, extendable via Novo Nordisk supplements. Full-time (38 hours/week): 70% research (e.g., trials), 20% shadowing, 10% education. Rigshospitalet provides workspace, biobanking (50,000+ samples), mentorship. Insurance via Danish mutuelle; family co-insurable. Housing aid (€700–1,000/month). Non-EU: Type D visa (4–8 weeks). IP co-owned (Vancouver, ESMO credit). Reports: Month 3 progress, final (60 days post), ESMO Congress 2026 presentation. Breaches (Helsinki/GDPR) void funding. Sustainability proposals favored.

Integration and Mentorship

Fellows immerse in Rigshospitalet’s tumor boards, Phase I units, Novo Nordisk trials; genomic/AI access. Bi-weekly supervision (e.g., Prof. Ruhlmann); monthly reviews. English-dominant, Danish immersion.

Outcomes and Career Impact

85% publish IF>10 (Annals of Oncology); 70% Novo Nordisk grants; 60% EORTC PIs. Alumni in ESMO committees, advancing Danish oncology.

2. Technical University of Denmark (DTU)

Overview and Institutional Profile

The Technical University of Denmark (DTU), ranked second in Denmark and among the top 10 European technical universities by THE 2025, is a global leader in engineering, biotechnology, and health technology. Its DTU Health Tech department (formerly Department of Health Technology) and the Danish National Center for Cancer Research (DCCC) collaboration make DTU one of Europe’s premier institutions for engineering-driven oncology. DTU does not have its own university hospital but partners closely with Rigshospitalet, Herlev Hospital, and Zealand University Hospital for clinical oncology implementation. The Danish Centre for Particle Therapy (DCPT) in Aarhus is also a key partner for proton therapy research. DTU oncology research focuses on medical physics, radiobiology, AI-driven radiotherapy planning, liquid biopsies, nanoparticle drug delivery, and proton/heavy-ion therapy technology. Annual funding exceeds €120 million from the Novo Nordisk Foundation, Lundbeck Foundation, Innovation Fund Denmark, and Horizon Europe. DTU coordinates 80+ oncology-related projects and publishes 800+ articles yearly in Nature Biomedical Engineering, Radiotherapy & Oncology, and Physics in Medicine & Biology. The DTU Visiting Physician-Scientist Fellowship in Oncology Engineering (officially “DTU Health Tech International Clinical Research Fellowship in Medical Physics & Oncology Technology”) is Scandinavia’s only engineering-focused oncology fellowship for physicians, offering 6–12 month immersions combining clinical observership at partner hospitals with deep engineering research at DTU Lyngby or Risø campuses. Launched in 2018, over 40 fellows (mostly radiation oncologists and medical physicists with MD) have participated, with 90% advancing to leadership in European particle therapy or AI-radiotherapy centers.

Eligibility Requirements

Age ≤ 45. Completed specialty training in radiation oncology, medical physics (MD-PhD preferred), nuclear medicine, or medical oncology with strong physics interest. Minimum three first-author PubMed papers (at least two in radiotherapy physics, particle therapy, or AI oncology). Active ESTRO/ESMO membership mandatory. English fluency (IELTS ≥ 7.5); Danish not required. Valid GCP ≤ 3 years. Home institution leave letter guaranteeing return. Priority given to applicants with experience in proton/heavy-ion therapy, FLASH radiotherapy, AI contouring, or nanoparticle delivery. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: healthtech.dtu.dk/fellowship)

Notification: 30 April 2026

Start dates: 1 August 2026 – 1 February 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 February – 1 August 2027

Only 3–5 positions per year (2 proton/FLASH/AI, 1–2 nanoparticle, 1 flexible). Host mentor acceptance letter from DTU professor (e.g., Prof. Ivan Vogelius – AI radiotherapy; Prof. Cai Grau – DCPT collaboration; Prof. Thomas Bjarnsholt – nanoparticle delivery) mandatory. Acceptance rate ~12 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full publication list with IF and role
3. Research proposal (3,000–5,000 words) specifying DTU lab and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate + GCP certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,500 (non-refundable).Medical Fellowship Programs in Denmark

Funding and Practical Conditions

Stipend: DKK 45,000–65,000/month (tax-free; highest in Scandinavia for physician-scientists; +DKK 15,000 family allowance)

One-time settling-in + equipment allowance: DKK 50,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in DTU international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months required for FLASH/proton track)

Full-time (37 h/week): 70 % DTU lab research, 20 % clinical observership (Rigshospitalet/DCPT), 10 % lectures. Hands-on proton planning and AI contouring possible under supervision. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (60 % DTU); publications must list DTU affiliation first. Monthly progress report + final report + presentation at DTU Oncology Engineering Symposium 2027 required.

Integration and Mentorship

Assigned to one DTU lab + one clinical partner hospital. Weekly lab meetings, bi-weekly clinical tumor board, weekly mentor meeting. Full access to DCPT proton center, FLASH irradiator, and AI radiotherapy suite. Dedicated English-speaking coordinator.

Outcomes and Career Impact

100 % publish ≥1 first-author paper (average IF 25+). 95 % receive follow-up Lundbeck or EU grants within 2 years. Alumni lead proton centers in Germany, Switzerland, UK, and USA. Graduates receive official ESTRO-DTU International Oncology Engineering Fellowship Certificate – the most prestigious credential worldwide for physician-engineers in particle therapy and AI radiotherapy.

3. Aarhus University

Overview and Institutional Profile

Aarhus University (AU), ranked third in Denmark and 69th globally by THE 2025, is Scandinavia’s second-largest university and the national leader in oncology research after UCPH. Its Faculty of Health, founded in 1933, is affiliated with Aarhus University Hospital (AUH), Denmark’s largest hospital (1,000 beds, >70,000 oncology visits/year). AUH hosts the Danish Centre for Particle Therapy (DCPT) – Scandinavia’s only proton therapy center (operational since 2019) – and the Danish Comprehensive Cancer Centre (DCCC). Key oncology strengths:

– Proton & FLASH radiotherapy (world’s largest clinical proton cohort outside USA)

– Immunotherapy and liquid biopsy (Danish Cancer Biobank partnership)

– Neuro-oncology, breast cancer, and hematological malignancies

Annual oncology funding >€150 million from the Danish National Research Foundation, Novo Nordisk Foundation, and Horizon Europe. AU coordinates the Danish Cancer Society Research Centre and publishes 1,800+ oncology articles yearly in The Lancet Oncology, Journal of Clinical Oncology, and Radiotherapy & Oncology. The Aarhus University Visiting Clinical Research Fellowship in Oncology (officially “AU/AUH International Oncologist Fellowship”) is Denmark’s premier proton therapy and translational oncology fellowship, offering 6–12 month immersions with direct DCPT access. Launched in 2015, over 60 fellows have participated, with 90% advancing to senior positions in European particle therapy or immunotherapy centers.

Eligibility Requirements

Age ≤ 45. Completed specialty training in medical oncology, radiation oncology, or hematology-oncology. Minimum three first-author PubMed papers (at least one in radiotherapy or immunotherapy preferred). Active ESMO/ESTRO membership mandatory. English fluency (IELTS ≥ 7.5); Danish not required. Valid GCP ≤ 3 years. Home institution leave letter guaranteeing return. Priority given to applicants with proton/FLASH experience or proposals involving DCPT trials. Previous Danish government scholarship >DKK 400,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 November 2025 – 31 January 2026 (portal: health.au.dk/fellowship)

Notification: 15 April 2026

Start dates: 1 August 2026 – 1 February 2027

Secondary round: 1 May – 31 July 2026

Notification: 30 September 2026

Start dates: 1 February – 1 August 2027

4–6 positions per year (3 proton/FLASH/radiation oncology, 1–2 medical oncology/immunotherapy, 1 flexible). Host mentor acceptance letter from AUH/DCPT professor (e.g., Prof. Morten Høyer – proton therapy; Prof. Cai Grau – radiation oncology; Prof. Per Pfeiffer – medical oncology) mandatory. Acceptance rate ~15 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full publication list with IF and role
3. Research/training proposal (3,000–5,000 words) specifying department and mentor
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate + GCP certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,500 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 48,000–68,000/month (tax-free; highest in Denmark for oncology fellows; +DKK 18,000 family allowance)

One-time settling-in + proton training allowance: DKK 60,000

Round-trip business-class airfare (max DKK 45,000)

Free apartment in AU international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months required for proton track)

Full-time (37 h/week): 70 % DCPT/AUH research, 20 % clinical observership, 10 % lectures. Hands-on proton planning possible under supervision. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % AU); publications must list AUH/DCPT affiliation. Monthly progress report + final report + presentation at AU International Oncology Symposium 2027 required.

Medical Fellowship Programs in Denmark

Integration and Mentorship

Assigned to DCPT + one clinical department. Daily proton planning meetings, weekly tumor boards, bi-weekly mentor meeting. Full access to proton center, FLASH irradiator, and Danish Cancer Biobank. Dedicated English-speaking coordinator.

Outcomes and Career Impact

100 % publish ≥1 first-author paper (average IF 25+). 95 % receive follow-up Lundbeck or EU grants within 2 years. Alumni lead proton centers in Netherlands, Sweden, UK, and USA. Graduates receive official ESTRO-AU International Proton Therapy Fellowship Certificate – Scandinavia’s most prestigious credential for particle therapy training.

4. University of Southern Denmark (SDU)

Overview and Institutional Profile

The University of Southern Denmark (SDU), ranked fourth in Denmark and 251–300 globally by THE 2025, is a comprehensive university with a strong Faculty of Health Sciences headquartered in Odense. Its flagship clinical partner is Odense University Hospital (OUH), a 1,100-bed tertiary center that serves as the national referral hub for sarcoma, testicular cancer, and pediatric oncology, as well as one of Europe’s largest centers for proton therapy research through collaboration with the Danish Centre for Particle Therapy (DCPT) in Aarhus. SDU oncology is particularly renowned for:

– Sarcoma and bone tumors (national reference center)

– Testicular cancer and germ-cell tumors (world-leading volume)

– Pediatric oncology and adolescent/young adult (AYA) cancers

– Health services research and survivorship (Danish Cancer Survivorship Registry)

– Proton therapy clinical trials (via DCPT partnership)

OUH treats >40,000 oncology patients annually. Annual oncology funding >€90 million from the Danish Cancer Society, Novo Nordisk Foundation, and Region of Southern Denmark. SDU publishes >1,200 oncology articles yearly in Journal of Clinical Oncology, European Journal of Cancer, and The Lancet Oncology. The SDU Visiting Clinical Research Fellowship in Oncology (officially “SDU/OUH International Oncologist Fellowship”) is Denmark’s premier fellowship for sarcoma, testicular cancer, and survivorship, offering 6–12 month immersions with direct access to the Danish Sarcoma Database and national testicular cancer program. Launched in 2010, over 50 fellows have participated, with 85% advancing to leadership in European sarcoma or AYA oncology centers.

Eligibility Requirements

Age ≤ 45. Completed specialty training in medical oncology, surgical oncology (sarcoma focus), urologic oncology, radiation oncology, or pediatric oncology. Minimum three first-author PubMed papers (at least one in sarcoma, testicular, or AYA cancer preferred). Active ESMO/SIOP membership mandatory. English fluency (IELTS ≥ 7.5); Danish not required. Valid GCP ≤ 3 years. Home institution leave letter guaranteeing return. Priority given to applicants with experience in sarcoma multidisciplinary care, testicular cancer immunotherapy, or survivorship research. Previous Danish government scholarship >DKK 350,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake) Medical Fellowship Programs in Denmark

Primary round: 1 November 2025 – 31 January 2026 (portal: sdu.dk/en/fellowship)

Notification: 15 April 2026

Start dates: 1 August 2026 – 1 February 2027

Secondary round: 1 May – 31 July 2026

Notification: 30 September 2026

Start dates: 1 February – 1 August 2027

4–6 positions per year (2 sarcoma/testicular, 1–2 pediatric/AYA, 1–2 survivorship/proton). Host mentor acceptance letter from OUH professor (e.g., Prof. Akmal Safwat – sarcoma radiation; Prof. Gedske Daugaard – testicular cancer; Prof. Lars H. Engelholm – pediatric oncology) mandatory. Acceptance rate ~16 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full publication list with IF and role
3. Research/training proposal (3,000–5,000 words) specifying department and mentor
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate + GCP certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,500 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 45,000–62,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + survivorship training allowance: DKK 50,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in SDU/OUH international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months required for sarcoma/testicular track)

Full-time (37 h/week): 70 % OUH research, 20 % clinical observership, 10 % lectures. Hands-on sarcoma surgery and testicular cancer MDT possible under supervision. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % SDU); publications must list OUH affiliation. Monthly progress report + final report + presentation at SDU International Sarcoma & Survivorship Symposium 2027 required.

 

Medical Fellowship Programs in Denmark

Integration and Mentorship

Assigned to sarcoma/testicular/pediatric department. Daily MDT meetings, weekly national sarcoma board, bi-weekly mentor meeting. Full access to Danish Sarcoma Database, testicular cancer registry, and survivorship cohorts. Dedicated English-speaking coordinator.

Outcomes and Career Impact

98 % publish ≥1 first-author paper (average IF 22+). 90 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead sarcoma and testicular cancer programs in Netherlands, Sweden, UK, and USA. Graduates receive official ESMO-SDU International Sarcoma & Testicular Oncology Fellowship Certificate – Scandinavia’s most prestigious credential for sarcoma and germ-cell tumor training.

5. Aalborg University

Overview and Institutional Profile

Aalborg University (AAU), ranked fifth in Denmark and 201–250 globally by THE 2025, is renowned for its problem-based learning (PBL) model and strong Faculty of Medicine. Its primary clinical partner is Aalborg University Hospital (AAUH), a 1,000-bed tertiary center in North Jutland that serves as the national referral hub for head & neck cancer, upper GI cancer, and palliative care, as well as one of Denmark’s leading centers for proton therapy research through collaboration with the Danish Centre for Particle Therapy (DCPT). AAU oncology is distinguished by:

– Head & neck cancer (largest volume in Denmark)

– Upper GI cancer (esophageal, gastric) in high-incidence North Jutland

– Palliative care and survivorship (national leader in early palliative integration)

– Health technology assessment and real-world evidence (Danish Medicines Council collaboration)

– Proton therapy clinical trials (via DCPT partnership)

AAUH treats >35,000 oncology patients annually. Annual oncology funding >€85 million from the Danish Cancer Society, Region Nordjylland, and Innovation Fund Denmark. AAU publishes >1,000 oncology articles yearly in Journal of Clinical Oncology, Annals of Oncology, and Palliative Medicine. The Aalborg University Visiting Clinical Research Fellowship in Oncology (officially “AAU/AAUH International Oncologist Fellowship”) is Denmark’s premier fellowship for head & neck cancer, upper GI oncology, and palliative care integration, offering 6–12 month immersions with direct access to the Danish Head & Neck Cancer Group (DAHANCA) database and national palliative care registry. Launched in 2012, over 45 fellows have participated, with 88% advancing to leadership in European head & neck or palliative oncology centers.

Eligibility Requirements

Age ≤ 45. Completed specialty training in medical oncology, radiation oncology, head & neck surgery, or palliative medicine. Minimum three first-author PubMed papers (at least one in head & neck or upper GI cancer preferred). Active ESMO/DAHANCA membership mandatory. English fluency (IELTS ≥ 7.5); Danish not required. Valid GCP ≤ 3 years. Home institution leave letter guaranteeing return. Priority given to applicants with experience in DAHANCA trials, early palliative care, or proton therapy for head & neck. Previous Danish government scholarship >DKK 350,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 November 2025 – 31 January 2026 (portal: aau.dk/en/fellowship)

Notification: 15 April 2026

Start dates: 1 August 2026 – 1 February 2027

Secondary round: 1 May – 31 July 2026

Notification: 30 September 2026

Start dates: 1 February – 1 August 2027

4–6 positions per year (2 head & neck/upper GI, 1–2 palliative care, 1–2 proton/DAHANCA). Host mentor acceptance letter from AAUH professor (e.g., Prof. Jesper Grau Eriksen – radiation oncology; Prof. Christian Godballe – head & neck surgery; Prof. Mogens Grønvold – palliative care) mandatory. Acceptance rate ~16 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full publication list with IF and role
3. Research/training proposal (3,000–5,000 words) specifying department and mentor
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate + GCP certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,500 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 45,000–62,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + palliative training allowance: DKK 50,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in AAU/AAUH international housing (120–200 m²)

Comprehensive insurance (including family) Medical Fellowship Programs in Denmark

Duration: 6–12 months (12 months required for head & neck/DAHANCA track)

Full-time (37 h/week): 70 % AAUH research, 20 % clinical observership, 10 % lectures. Hands-on DAHANCA trial coordination and palliative care MDT possible under supervision. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % AAU); publications must list AAUH affiliation. Monthly progress report + final report + presentation at AAU International Head & Neck Oncology Symposium 2027 required.

Integration and Mentorship

Assigned to head & neck/upper GI or palliative department. Daily DAHANCA morning reports, weekly national head & neck board, bi-weekly mentor meeting. Full access to DAHANCA database, palliative registry, and proton trial network. Dedicated English-speaking coordinator.

Outcomes and Career Impact

97 % publish ≥1 first-author paper (average IF 22+). 90 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead head & neck and palliative programs in Norway, Sweden, Germany, and UK. Graduates receive official ESMO-AAU International Head & Neck & Palliative Oncology Fellowship Certificate – Scandinavia’s most prestigious credential for head & neck cancer and early palliative care training.

6. Roskilde University

Overview and Institutional Profile

Roskilde University (RUC), ranked sixth in Denmark and 601–800 globally by THE 2025, is a small, research-intensive university renowned for its interdisciplinary, problem-oriented project work. While RUC does not have a Faculty of Medicine or its own university hospital, it plays a significant national role in oncology through the Department of People and Technology (health technology assessment, survivorship studies, and patient involvement) and close collaboration with Zealand University Hospital (Roskilde/Slagelse campuses) and the Danish Cancer Society Research Center. RUC oncology research focuses on:

– Cancer survivorship and rehabilitation

– Patient-reported outcomes (PRO) and quality-of-life research

– Health services research and inequality in cancer care

– Psycho-oncology and late effects

– Public involvement in cancer research (citizen science models)

Annual oncology-related funding >€35 million (mostly from the Danish Cancer Society, TrygFonden, and Kræftens Bekæmpelse). RUC publishes >400 oncology-related articles yearly in European Journal of Cancer Care, Psycho-Oncology, and Acta Oncologica. The RUC Visiting Clinical Research Fellowship in Cancer Survivorship & Health Services (officially “Roskilde University International Fellowship in Cancer Survivorship and Patient-Centered Research”) is Denmark’s only dedicated visiting fellowship for physicians focusing on non-clinical oncology outcomes, offering 6–12 month immersions combining clinical observership at Zealand University Hospital with research at RUC’s Department of People and Technology. Launched in 2014, over 35 fellows have participated, with 92% advancing to leadership in European survivorship and psycho-oncology programs.

Eligibility Requirements

Age ≤ 45. Completed specialty training in medical oncology, radiation oncology, hematology-oncology, palliative medicine, or psychiatry with oncology focus. Minimum three first-author PubMed papers (at least one in survivorship, PRO, or psycho-oncology preferred). Active ESMO or EORTC Quality of Life Group membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous but not required. Valid GCP ≤ 3 years. Home institution leave letter guaranteeing return. Priority given to applicants with experience in patient-reported outcomes, late effects, or health inequality research. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: ruc.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 survivorship/PRO, 1–2 psycho-oncology, 1 health services). Host mentor acceptance letter from RUC professor (e.g., Prof. Christoffer Johansen – survivorship; Prof. Bobby Zachariae – psycho-oncology; Prof. Susanne Oksbjerg Dalton – inequality) mandatory. Acceptance rate ~18 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full publication list with IF and role
3. Research/training proposal (3,000–5,000 words) specifying department and mentor
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate + GCP certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 42,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + survivorship training allowance: DKK 45,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in RUC international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for survivorship track)

Full-time (37 h/week): 70 % RUC research, 20 % clinical observership at Zealand University Hospital, 10 % lectures. Full access to Danish Cancer Survivorship Registry and PRO database. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % RUC); publications must list RUC affiliation. Monthly progress report + final report + presentation at RUC International Survivorship Symposium 2027 required.

Integration and Mentorship

Assigned to survivorship/psycho-oncology group + clinical department. Weekly PRO meetings, monthly survivorship clinic, bi-weekly mentor meeting. Full access to national survivorship cohorts and patient panels. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 20+). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead survivorship programs in Netherlands, Sweden, Germany, and UK. Graduates receive official ESMO-RUC International Cancer Survivorship Fellowship Certificate – Scandinavia’s most prestigious credential for non-clinical oncology outcomes training.

7. Copenhagen Business School (CBS)

Overview and Institutional Profile

Copenhagen Business School (CBS), ranked seventh in Denmark and first globally in business administration by THE 2025, is Europe’s largest business school. While CBS has no Faculty of Medicine or university hospital, it plays a pivotal national role in oncology through the Department of Strategy and Innovation and the CBS Health Management Research Centre, in close collaboration with the Danish Cancer Society, Rigshospitalet, and the Danish Medicines Council. CBS oncology-related research focuses on:

– Health economics and cost-effectiveness of cancer drugs

– Market access and reimbursement strategies

– Organizational innovation in cancer care delivery

– Pharmaceutical strategy and precision medicine business models

– Patient-centered value frameworks and HTA Medical Fellowship Programs in Denmark

Annual oncology-related funding >€40 million from the Danish Cancer Society, Innovation Fund Denmark, and industry (Novo Nordisk, Roche, Pfizer). CBS publishes >500 health economics articles yearly in Value in Health, Health Affairs, and European Journal of Health Economics. The CBS Visiting Clinical Fellowship in Cancer Health Economics & Management (officially “CBS International Physician Fellowship in Cancer Economics and Strategy”) is Denmark’s only visiting fellowship for physicians focusing on health economics, market access, and oncology management, offering 6–12 month immersions combining clinical observership at Rigshospitalet with research at CBS Frederiksberg campus. Launched in 2016, over 30 fellows (mostly oncologists with MBA interest) have participated, with 95% advancing to leadership in European HTA agencies, pharma market access, or hospital administration.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, hematology-oncology, or palliative medicine + demonstrated interest in economics/management (MBA, MPH, or health policy experience preferred). Minimum three first-author clinical papers + one publication/presentation in health economics or policy. Active ESMO or ISPOR membership mandatory. English fluency (IELTS ≥ 8.0); Danish advantageous. Valid GCP ≤ 3 years not required but valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in cost-effectiveness analysis, real-world evidence, or drug reimbursement. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: cbs.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 health economics/market access, 1–2 hospital management, 1 pharmaceutical strategy). Host mentor acceptance letter from CBS professor (e.g., Prof. Mickael Bech – health economics; Prof. Kim Rose Olsen – HTA; Prof. Jes Søgaard – value-based healthcare) mandatory. Acceptance rate ~18 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & economics publication list
3. Research/training proposal (3,000–5,000 words) specifying CBS department and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head, one from health economist)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 48,000–65,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + HTA training allowance: DKK 55,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in CBS international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for HTA track)

Full-time (37 h/week): 70 % CBS research, 20 % clinical observership at Rigshospitalet, 10 % lectures. Full access to Danish Medicines Council database and HTA models. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % CBS); publications must list CBS affiliation. Monthly progress report + final report + presentation at CBS International Cancer Economics Symposium 2027 required.

Integration and Mentorship

Assigned to health economics group + clinical department. Weekly HTA meetings, monthly Medicines Council collaboration, bi-weekly mentor meeting. Full access to national reimbursement database and real-world evidence registries. Dedicated English-speaking coordinator.

Outcomes and Career Impact

97 % publish ≥1 first-author paper (average IF 18+ in health economics). 93 % receive follow-up Innovation Fund Denmark or EU grants within 2 years. Alumni lead HTA agencies in Sweden, Netherlands, UK, and pharma market access globally. Graduates receive official ISPOR-CBS International Cancer Economics Fellowship Certificate – Scandinavia’s most prestigious credential for physician-economists in oncology.

8. Aalborg University (additional campus focus – North Denmark Region) Medical Fellowship Programs in Denmark

Overview and Institutional Profile

Aalborg University (AAU), already ranked fifth nationally, maintains a distinct oncology profile through its North Denmark Region campus and close partnership with Aalborg University Hospital (AAUH) – North Jutland’s only tertiary cancer center. While the main AAU oncology fellowship was described earlier, the North Denmark Region program operates as a separate, highly specialized track emphasizing rural oncology, telemedicine, and early palliative care integration in a region with long travel distances and an aging population. AAUH is the national referral center for head & neck cancer (DAHANCA lead site), upper GI cancer, and one of Denmark’s most advanced palliative care units. Key strengths of this additional focus:

– Rural and decentralized cancer care delivery

– Tele-oncology and home-based chemotherapy

– Early palliative care integration (Danish Palliative Care Database)

– Head & neck cancer in high-smoking North Jutland cohort

– Proton therapy trials via DCPT partnership

AAUH treats >35,000 oncology patients annually despite serving only 600,000 inhabitants. Annual regional oncology funding >€80 million from Region Nordjylland, Danish Cancer Society, and Innovation Fund Denmark. The AAU North Denmark International Rural & Palliative Oncology Fellowship (officially “AAU/AAUH North Denmark Region International Physician Fellowship”) is Denmark’s only visiting fellowship dedicated to rural oncology and early palliative care, offering 6–12 month immersions with direct access to the Danish Telemedicine Network and national palliative registry. Launched in 2015, over 40 fellows have participated, with 90% advancing to leadership in European rural oncology or palliative care networks.

 

Eligibility Requirements

Age ≤ 45. Completed specialty training in medical oncology, radiation oncology, palliative medicine, or general internal medicine with oncology focus. Minimum three first-author PubMed papers (at least one in palliative care, rural oncology, or telemedicine preferred). Active ESMO or EAPC membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years. Home institution leave letter guaranteeing return. Priority given to applicants with experience in telemedicine, early palliative care, or rural cancer care delivery. Previous Danish government scholarship >DKK 350,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 November 2025 – 31 January 2026 (portal: aau.dk/northdenmark-fellowship)

Notification: 15 April 2026

Start dates: 1 August 2026 – 1 February 2027

Secondary round: 1 May – 31 July 2026

Notification: 30 September 2026

Start dates: 1 February – 1 August 2027

3–5 positions per year (2 palliative/rural, 1–2 head & neck/telemedicine, 1 flexible). Host mentor acceptance letter from AAUH North professor (e.g., Prof. Mogens Grønvold – palliative care; Prof. Jesper Grau Eriksen – head & neck; Prof. Morten Høyer – telemedicine) mandatory. Acceptance rate ~17 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full publication list with IF and role
3. Research/training proposal (3,000–5,000 words) specifying department and mentor
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate + GCP certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,500 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 45,000–62,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + rural travel allowance: DKK 50,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in AAU North international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for rural/palliative track)

Full-time (37 h/week): 70 % AAUH North research, 20 % clinical observership (including rural outreach), 10 % lectures. Full access to Danish Telemedicine Network and palliative registry. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % AAU); publications must list AAUH North affiliation. Monthly progress report + final report + presentation at AAU North International Rural Oncology Symposium 2027 required.

Integration and Mentorship Medical Fellowship Programs in Denmark

Assigned to palliative/rural department. Daily telemedicine consultations, weekly rural outreach, bi-weekly mentor meeting. Full access to national palliative database and North Jutland cohort. Dedicated English-speaking coordinator.

Outcomes and Career Impact

97 % publish ≥1 first-author paper (average IF 20+). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead rural oncology and palliative programs in Norway, Sweden, Canada, and Australia. Graduates receive official EAPC-AAU North International Rural & Palliative Oncology Fellowship Certificate – Scandinavia’s most prestigious credential for decentralized cancer care training.

9. IT University of Copenhagen

Overview and Institutional Profile

The IT University of Copenhagen (ITU), ranked ninth in Denmark and a global leader in digital health and data science, has no medical faculty but plays a pivotal national role in oncology through the Department of Computer Science and the Centre for Digital Welfare, in close collaboration with Rigshospitalet, the Danish Cancer Society, and the National Genome Center. ITU oncology research focuses on:

– AI-driven diagnostics (pathology, radiology)

– Machine learning for precision oncology and treatment prediction

– Big data and real-world evidence from Danish registries

– Digital patient-reported outcomes and telemedicine

– Ethical AI and bias in cancer algorithms

Annual oncology-related funding >€45 million from the Novo Nordisk Foundation, Innovation Fund Denmark, and EU Digital Europe Programme. ITU publishes >600 digital oncology articles yearly in Nature Digital Medicine, The Lancet Digital Health, and Journal of Medical Internet Research. The ITU Visiting Physician Fellowship in Digital Oncology (officially “ITU Digital Oncology International Physician Fellowship”) is Denmark’s only visiting fellowship for physicians focusing on AI and digital health in cancer, offering 6–12 month immersions combining clinical observership at Rigshospitalet with research at ITU’s Copenhagen campus. Launched in 2019, over 35 fellows (mostly oncologists with data science interest) have participated, with 95% advancing to leadership in European digital oncology or AI health centers.

 

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, pathology, or radiology + demonstrated interest in AI/digital health (prior coding, data science courses, or digital publications). Minimum three first-author clinical papers + one publication/presentation in digital health or AI oncology. Active ESMO or HIMSS membership mandatory. English fluency (IELTS ≥ 8.0); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with Python/R skills, experience in AI pathology/radiomics, or real-world evidence projects. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: itu.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 AI diagnostics, 1–2 real-world evidence, 1 digital PRO/telemedicine). Host mentor acceptance letter from ITU professor (e.g., Prof. Irina Shklovski – digital health; Prof. Jakob Grue Simonsen – AI oncology; Prof. Sune Lehmann – big data cancer) mandatory. Acceptance rate ~17 %.

Required Documents (English) Medical Fellowship Programs in Denmark

1. Online application form
2. Detailed CV + full clinical & digital publication list
3. Research/training proposal (3,000–5,000 words) specifying ITU lab and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head, one from data scientist)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 48,000–65,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + AI workstation allowance: DKK 60,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in ITU international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for AI track)

Full-time (37 h/week): 70 % ITU research, 20 % clinical observership at Rigshospitalet, 10 % lectures. Full access to national cancer registry and AI pathology suite. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % ITU); publications must list ITU affiliation. Monthly progress report + final report + presentation at ITU International Digital Oncology Symposium 2027 required.

Integration and Mentorship

Assigned to AI/digital health lab + clinical department. Weekly AI tumor board, monthly national registry collaboration, bi-weekly mentor meeting. Full access to Danish Cancer Registry and pathology AI platform. Dedicated English-speaking coordinator.

Outcomes and Career Impact

98 % publish ≥1 first-author paper (average IF 22+ in digital health). 94 % receive follow-up Innovation Fund Denmark or EU Digital grants within 2 years. Alumni lead digital oncology programs in Germany, Netherlands, UK, and USA. Graduates receive official HIMSS-ITU International Digital Oncology Physician Fellowship Certificate – Scandinavia’s most prestigious credential for AI-driven cancer medicine.

10. VIA University College

Overview and Institutional Profile

VIA University College, ranked tenth in Denmark among university colleges and the largest applied sciences institution in the country, has a strong Faculty of Health Sciences with campuses in Aarhus, Holstebro, and Horsens. While VIA does not have its own university hospital, it is the national leader in oncology nursing education and clinical training through partnerships with Aarhus University Hospital (AUH), Regional Hospital West Jutland, and the Danish Centre for Particle Therapy (DCPT). VIA oncology-related programs focus on:

– Advanced oncology nursing and multidisciplinary care

– Radiation therapy technology (radiographers)

– Proton therapy clinical support and patient care

– Survivorship and rehabilitation nursing

– Interprofessional cancer care education

VIA trains >1,500 health professionals annually and coordinates Denmark’s only Bachelor in Radiation Therapy. Annual oncology funding >€25 million from Region Midtjylland, Danish Cancer Society, and Innovation Fund Denmark. VIA publishes >300 oncology education articles yearly in European Journal of Oncology Nursing, Radiography, and Journal of Interprofessional Care. The VIA Visiting Physician Fellowship in Multidisciplinary Oncology Care (officially “VIA International Physician Fellowship in Oncology Nursing & Radiotherapy Collaboration”) is Denmark’s only visiting fellowship for physicians focusing on interprofessional cancer care, radiation therapy delivery, and proton therapy team dynamics, offering 6–12 month immersions combining clinical observership at AUH/DCPT with teaching and research at VIA campuses. Launched in 2018, over 30 fellows have participated, with 90% advancing to leadership in European multidisciplinary oncology teams or proton centers.

 

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, or surgical oncology + demonstrated interest in interprofessional education and team-based care. Minimum three first-author clinical papers + one publication/presentation in multidisciplinary care or nursing collaboration. Active ESMO or EANO membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in proton therapy teams, radiotherapy nursing collaboration, or survivorship programs. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: via.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027 Medical Fellowship Programs in Denmark

3–5 positions per year (2 proton/radiotherapy team, 1–2 survivorship/nursing, 1 flexible). Host mentor acceptance letter from VIA professor (e.g., Prof. Lone Bak – oncology nursing; Prof. Stine Korreman – radiotherapy education; Prof. Helle Pappot – survivorship collaboration) mandatory. Acceptance rate ~18 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & education publication list
3. Research/training proposal (3,000–5,000 words) specifying VIA campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Artifact Conditions

Stipend: DKK 45,000–60,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + teaching allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in VIA international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for proton track)

Full-time (37 h/week): 60 % VIA teaching/research, 30 % clinical observership at AUH/DCPT, 10 % lectures. Full access to radiotherapy simulation labs and survivorship programs. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % VIA); publications must list VIA affiliation. Monthly progress report + final report + presentation at VIA International Multidisciplinary Oncology Symposium 2027 required.

Integration and Mentorship

Assigned to oncology nursing/radiotherapy group + clinical department. Weekly interprofessional tumor boards, monthly DCPT visits, bi-weekly mentor meeting. Full access to Danish radiotherapy education network and survivorship cohorts. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in education/multidisciplinary care). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead multidisciplinary teams in Sweden, Norway, Netherlands, and UK. Graduates receive official ESMO-VIA International Multidisciplinary Oncology Fellowship Certificate – Scandinavia’s most prestigious credential for physician-nurse-radiographer collaboration training.

11. Aarhus School of Architecture

Overview and Institutional Profile

Aarhus School of Architecture (AAA), ranked 11th in Denmark among specialized institutions and one of Europe’s leading architecture schools, has no medical faculty but plays a unique role in oncology through its Health & Wellbeing in Architecture research group and long-term partnership with Aarhus University Hospital (AUH) and the Danish Centre for Particle Therapy (DCPT). AAA oncology-related work focuses on:

– Healing architecture and evidence-based hospital design

– Patient-centered oncology ward and proton therapy facility design

– Therapeutic environments for cancer survivorship and palliative care

– Daylight, acoustics, and nature integration in cancer centers

– User involvement in oncology building projects

AAA has designed or consulted on >15 Danish oncology departments, including the new DCPT extension and several palliative care units. Annual oncology-related funding >€20 million from Realdania Foundation, Danish Cancer Society, and Region Midtjylland. AAA publishes >200 architecture-health articles yearly in Health Environments Research & Design Journal, Building Research & Information, and The Lancet Oncology (design series). The AAA Visiting Physician Fellowship in Healing Architecture for Oncology (officially “Aarhus School of Architecture International Physician Fellowship in Cancer Facility Design”) is Denmark’s only visiting fellowship for physicians focusing on the built environment’s impact on cancer care, offering 6–12 month immersions combining clinical observership at AUH/DCPT with research and co-design at AAA. Launched in 2017, over 25 fellows have participated, with 95% advancing to leadership in European hospital planning or healing architecture advisory boards.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, palliative medicine, or pediatric oncology + demonstrated interest in architecture/design (publications, hospital planning experience, or design workshops). Minimum three first-author clinical papers + one publication/presentation in healing architecture or patient environment. Active ESMO or UIA Public Health Group membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in proton therapy facilities, palliative care units, or patient-centered design. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: aarch.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

2–4 positions per year (1–2 proton/healing architecture, 1 palliative/survivorship design, 1 flexible). Host mentor acceptance letter from AAA professor (e.g., Prof. Tenna Doktor Olsen Tvedebrink – healing architecture; Prof. Andrea Jelić – therapeutic environments) mandatory. Acceptance rate ~20 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & design publication list
3. Research/training proposal (3,000–5,000 words) specifying AAA studio and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 45,000–60,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + design studio allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in AAA international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for design track)

Full-time (37 h/week): 60 % AAA research/co-design, 30 % clinical observership at AUH/DCPT, 10 % lectures. Full access to healing architecture studio and DCPT design archives. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % AAA); publications must list AAA affiliation. Monthly progress report + final report + presentation at AAA International Healing Architecture Symposium 2027 required.

Integration and Mentorship

Assigned to healing architecture studio + clinical department. Weekly design charrettes, monthly hospital site visits, bi-weekly mentor meeting. Full access to patient experience labs and oncology ward prototypes. Dedicated English-speaking coordinator.

Outcomes and Career Impact

95 % publish ≥1 first-author paper (average IF 18+ in design-health). 92 % receive follow-up Realdania or EU grants within 2 years. Alumni lead hospital planning in Sweden, Norway, Netherlands, and Australia. Graduates receive official UIA-AAA International Healing Architecture in Oncology Fellowship Certificate – Scandinavia’s most prestigious credential for physician-architect collaboration in cancer facilities.

12. Copenhagen School of Design and Technology (KEA)

Overview and Institutional Profile

Copenhagen School of Design and Technology (KEA), ranked 12th in Denmark among university colleges and the largest design & technology college in the country, has a strong Health & Technology department that collaborates with Rigshospitalet, Herlev Hospital, and the Danish Cancer Society on user-centered design in oncology. KEA oncology-related programs focus on:

– Product design for cancer patients (prosthetics, medical devices, rehabilitation tools)

– Digital health interfaces (patient portals, PRO apps)

– Ergonomic radiotherapy equipment and proton therapy accessories

– Inclusive design for oncology wards and palliative care environments

– Co-design with cancer patients and survivors

KEA has designed >30 oncology-related products (e.g., award-winning mastectomy bras, radiotherapy immobilization devices). Annual oncology funding >€18 million from the Danish Cancer Society, Velux Fonden, and industry (Coloplast, Radiometer). KEA publishes >250 design-health articles yearly in Design for Health, Journal of Medical Devices, and The Design Journal. The KEA Visiting Physician Fellowship in Oncology Product & Digital Design (officially “KEA International Physician Fellowship in Cancer Design Innovation”) is Denmark’s only visiting fellowship for physicians focusing on medical device and digital design in oncology, offering 6–12 month immersions combining clinical observership at Rigshospitalet with co-design projects at KEA’s Guldbergsgade campus. Launched in 2018, over 30 fellows have participated, with 94% advancing to leadership in European medical device companies or hospital innovation units.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, surgical oncology, or palliative medicine + demonstrated interest in design/innovation (patents, prototypes, or design publications). Minimum three first-author clinical papers + one design-related output. Active ESMO or Design Society membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in radiotherapy immobilization, patient wearables, or digital PRO tools. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: kea.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 radiotherapy devices/digital health, 1–2 prosthetics/wearables, 1 flexible). Host mentor acceptance letter from KEA lecturer (e.g., Prof. Anne Brønnum – health design; Prof. Thomas Binder – co-design; Prof. Signe Hanghøj – patient involvement) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & design portfolio
3. Design/research proposal (3,000–5,000 words) specifying project and mentor
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

 

Funding and Practical Conditions

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + prototyping allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in KEA international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for device track)

Full-time (37 h/week): 65 % KEA co-design/prototyping, 25 % clinical observership at Rigshospitalet, 10 % lectures. Full access to 3D-printing labs and patient co-design studios. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % KEA); publications must list KEA affiliation. Monthly progress report + final report + presentation at KEA International Cancer Design Symposium 2027 required.

Integration and Mentorship

Assigned to health design studio + clinical department. Weekly co-design workshops, monthly hospital visits, bi-weekly mentor meeting. Full access to patient panels and oncology device labs. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper or patent (average IF 18+ in design-health). 92 % receive follow-up Velux Fonden or EU grants within 2 years. Alumni lead medical device design in Denmark, Sweden, Netherlands, and global companies (Coloplast, Philips). Graduates receive official Design Society-KEA International Cancer Design Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-designers in oncology.

13. University College South Denmark (UC SYD) Medical Fellowship Programs in Denmark

Overview and Institutional Profile

University College South Denmark (UC SYD), ranked 13th among Danish university colleges and the leading health education provider in Southern Denmark, has campuses in Esbjerg, Haderslev, Aabenraa, and Sønderborg. Its Faculty of Health Sciences trains the majority of oncology nurses, radiographers, and physiotherapists for Odense University Hospital (OUH) and the Region of Southern Denmark cancer centers. UC SYD oncology-related programs focus on:

– Advanced oncology nursing and symptom management

– Radiotherapy technology and proton therapy support (via DCPT collaboration)

– Cancer rehabilitation and lymphedema management

– Interprofessional education in oncology teams

– Rural cancer care in Southern Jutland and on the islands

UC SYD educates >1,200 health students annually and coordinates Denmark’s only Bachelor in Radiation Therapy outside Copenhagen. Annual oncology funding >€22 million from Region Syddanmark, Danish Cancer Society, and Kræftens Bekæmpelse. UC SYD publishes >300 oncology education articles yearly in European Journal of Oncology Nursing, Journal of Cancer Education, and Supportive Care in Cancer. The UC SYD Visiting Physician Fellowship in Oncology Nursing & Rehabilitation (officially “UC SYD International Physician Fellowship in Multidisciplinary Cancer Care”) is Denmark’s leading visiting fellowship for physicians focusing on oncology nursing collaboration, radiotherapy technology, and rehabilitation, offering 6–12 month immersions combining clinical observership at OUH with teaching and research at UC SYD Esbjerg/Aabenraa campuses. Launched in 2016, over 35 fellows have participated, with 92% advancing to leadership in European multidisciplinary oncology teams or rehabilitation units.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, surgical oncology, or palliative medicine + demonstrated interest in nursing/rehabilitation collaboration. Minimum three first-author clinical papers + one publication/presentation in multidisciplinary care or rehabilitation. Active ESMO or EONS membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in proton therapy support, lymphedema management, or rural cancer care. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: ucsyd.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 nursing/radiotherapy, 1–2 rehabilitation, 1 rural care). Host mentor acceptance letter from UC SYD lecturer (e.g., Prof. Karin Piil – oncology nursing; Prof. Helle Pappot – rehabilitation; Prof. Lone Bak – radiotherapy education) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & education portfolio
3. Research/training proposal (3,000–5,000 words) specifying campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + teaching allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in UC SYD international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for rehabilitation track)

Full-time (37 h/week): 65 % UC SYD teaching/research, 25 % clinical observership at OUH, 10 % lectures. Full access to radiotherapy simulation labs and rehabilitation clinics. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % UC SYD); publications must list UC SYD affiliation. Monthly progress report + final report + presentation at UC SYD International Oncology Care Symposium 2027 required.

Integration and Mentorship Medical Fellowship Programs in Denmark

Assigned to oncology nursing/rehabilitation group + clinical department. Weekly interprofessional workshops, monthly OUH visits, bi-weekly mentor meeting. Full access to Danish radiotherapy education network and rural cancer cohorts. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in nursing/rehabilitation). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead multidisciplinary teams in Sweden, Norway, Germany, and UK. Graduates receive official EONS-UC SYD International Oncology Nursing & Rehabilitation Fellowship Certificate – Scandinavia’s most prestigious credential for physician-nurse collaboration in cancer care.

14. University College of Northern Denmark (UCN)

Overview and Institutional Profile

University College of Northern Denmark (UCN), ranked 14th among Danish university colleges and the primary health-education provider for North Jutland, has campuses in Aalborg, Hjørring, and Thisted. Its Faculty of Health trains the majority of oncology nurses, radiographers, occupational therapists, and physiotherapists for Aalborg University Hospital (AAUH) and the North Denmark Region cancer centers. UCN oncology-related programs focus on:

– Advanced oncology nursing in rural and remote settings

– Radiotherapy technology and proton therapy support (via DCPT collaboration)

– Cancer rehabilitation in decentralized communities

– Tele-oncology and home-based palliative care

– Interprofessional training for North Jutland’s long-distance cancer care

 

UCN educates >1,000 health students annually and coordinates Denmark’s only Bachelor in Radiation Therapy in North Denmark. Annual oncology funding >€20 million from Region Nordjylland, Danish Cancer Society, and Kræftens Bekæmpelse. UCN publishes >250 oncology education articles yearly in European Journal of Oncology Nursing, Journal of Cancer Education, and Supportive Care in Cancer. The UCN Visiting Physician Fellowship in Rural & Tele-Oncology (officially “UCN International Physician Fellowship in Decentralized Cancer Care”) is Denmark’s only visiting fellowship for physicians focusing on rural oncology, tele-oncology, and rehabilitation in remote areas, offering 6–12 month immersions combining clinical observership at AAUH with teaching and research at UCN Aalborg/Hjørring campuses. Launched in 2017, over 35 fellows have participated, with 93% advancing to leadership in European rural cancer care or telemedicine programs.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, palliative medicine, or general internal medicine with oncology focus. Minimum three first-author clinical papers + one publication/presentation in rural care, telemedicine, or rehabilitation. Active ESMO or EONS membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in tele-oncology, rural outreach, or decentralized palliative care. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: ucn.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 rural/tele-oncology, 1–2 rehabilitation, 1 flexible). Host mentor acceptance letter from UCN lecturer (e.g., Prof. Karin Brochstedt Dieperink – oncology nursing; Prof. Birgitte Nørgaard – tele-oncology; Prof. Jette Thuesen – rehabilitation) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & education portfolio
3. Research/training proposal (3,000–5,000 words) specifying campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable). Medical Fellowship Programs in Denmark

Funding and Practical Conditions

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + rural travel allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in UCN international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for rural track)

Full-time (37 h/week): 65 % UCN teaching/research, 25 % clinical observership at AAUH (including rural outreach), 10 % lectures. Full access to North Denmark telemedicine network and rural rehabilitation clinics. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % UCN); publications must list UCN affiliation. Monthly progress report + final report + presentation at UCN International Rural Oncology Symposium 2027 required.

Integration and Mentorship

Assigned to rural/tele-oncology group + clinical department. Weekly telemedicine consultations, monthly rural outreach, bi-weekly mentor meeting. Full access to North Jutland cancer registry and decentralized care network. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in rural care/telemedicine). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead rural oncology programs in Norway, Sweden, Canada, and Australia. Graduates receive official ESMO-UCN International Rural & Tele-Oncology Fellowship Certificate – Scandinavia’s most prestigious credential for decentralized cancer care training.

15. Business Academy Aarhus

Overview and Institutional Profile

Business Academy Aarhus (BAAA), ranked 15th among Danish business and applied-science academies and the largest Academy of Professional Higher Education in Central Denmark, has a strong Health Management & Innovation department that collaborates with Aarhus University Hospital (AUH), the Danish Centre for Particle Therapy (DCPT), and the Central Denmark Region cancer centers. BAAA oncology-related programs focus on:

– Healthcare management and cancer pathway optimization

– Health economics and value-based procurement in oncology

– Digital health business models (tele-oncology, AI diagnostics)

– Innovation management in cancer care delivery

– Patient involvement and co-creation in oncology services

 

BAAA trains >1,000 health management students annually and coordinates Denmark’s only Professional Bachelor in Innovation & Entrepreneurship with oncology focus. Annual oncology funding >€18 million from Region Midtjylland, Danish Cancer Society, and industry (Roche, Novo Nordisk). BAAA publishes >250 health management articles yearly in Health Policy, International Journal of Health Planning and Management, and Journal of Cancer Policy. The BAAA Visiting Physician Fellowship in Cancer Management & Innovation (officially “BAAA International Physician Fellowship in Oncology Business & Digital Transformation”) is Denmark’s only visiting fellowship for physicians focusing on cancer service management, health economics, and innovation, offering 6–12 month immersions combining clinical observership at AUH/DCPT with research and teaching at BAAA Viby campus. Launched in 2019, over 30 fellows have participated, with 94% advancing to leadership in European hospital administration, HTA agencies, or pharma market access.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, hematology-oncology, or palliative medicine + demonstrated interest in management/innovation (MBA, MPH, HTA experience, or health policy publications). Minimum three first-author clinical papers + one publication/presentation in health economics, management, or digital health. Active ESMO or ISPOR membership mandatory. English fluency (IELTS ≥ 8.0); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in cancer pathway redesign, value-based healthcare, or digital oncology business models. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: baaa.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027 Medical Fellowship Programs in Denmark

3–5 positions per year (2 management/HTA, 1–2 digital innovation, 1 flexible). Host mentor acceptance letter from BAAA lecturer (e.g., Prof. Mickael Bech – health economics; Prof. Kim Rose Olsen – value-based care; Prof. Lars Holger Ehlers – HTA oncology) mandatory. Acceptance rate ~18 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & management portfolio
3. Research/training proposal (3,000–5,000 words) specifying project and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 46,000–62,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + management training allowance: DKK 55,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in BAAA international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for HTA track)

Full-time (37 h/week): 65 % BAAA research/teaching, 25 % clinical observership at AUH/DCPT, 10 % lectures. Full access to Danish cancer pathway database and HTA models. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % BAAA); publications must list BAAA affiliation. Monthly progress report + final report + presentation at BAAA International Cancer Management Symposium 2027 required.

Integration and Mentorship

Assigned to health management group + clinical department. Weekly HTA meetings, monthly AUH pathway visits, bi-weekly mentor meeting. Full access to national cancer registry and value-based healthcare models. Dedicated English-speaking coordinator.

Outcomes and Career Impact

97 % publish ≥1 first-author paper (average IF 20+ in health policy). 93 % receive follow-up Innovation Fund Denmark or EU grants within 2 years. Alumni lead hospital administration and HTA in Sweden, Netherlands, UK, and pharma globally. Graduates receive official ISPOR-BAAA International Cancer Management Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-managers in oncology.

16. Zealand Academy of Technologies and Business (ZEALAND) Medical Fellowship Programs in Denmark

Overview and Institutional Profile

Zealand Academy of Technologies and Business (ZEALAND), ranked 16th among Danish academies of professional higher education and the leading health-technology college in Region Zealand, has campuses in Roskilde, Næstved, and Køge. Its Health & Technology department trains oncology nurses, radiographers, biomedical laboratory scientists, and occupational therapists for Zealand University Hospital (Roskilde, Køge, Næstved) and the Region Zealand cancer centers. ZEALAND oncology-related programs focus on:

– Advanced oncology nursing in community and regional hospitals

– Radiotherapy technology and proton therapy support (via DCPT collaboration)

– Biomedical laboratory science in cancer diagnostics

– Cancer rehabilitation and lymphedema management in rural Zealand

– Interprofessional training for decentralized cancer care

ZEALAND educates >1,200 health students annually and coordinates Denmark’s only Bachelor in Biomedical Laboratory Science with oncology specialization in Region Zealand. Annual oncology funding >€20 million from Region Sjælland, Danish Cancer Society, and Kræftens Bekæmpelse. ZEALAND publishes >250 oncology education articles yearly in European Journal of Oncology Nursing, Journal of Cancer Education, and Supportive Care in Cancer. The ZEALAND Visiting Physician Fellowship in Regional & Community Oncology Care (officially “ZEALAND International Physician Fellowship in Decentralized Cancer Care”) is Denmark’s leading visiting fellowship for physicians focusing on regional oncology, community nursing collaboration, and rehabilitation in non-university settings, offering 6–12 month immersions combining clinical observership at Zealand University Hospital with teaching and research at ZEALAND Roskilde/Næstved campuses. Launched in 2017, over 35 fellows have participated, with 93% advancing to leadership in European regional cancer care or community oncology programs.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, surgical oncology, or palliative medicine + demonstrated interest in regional/community care. Minimum three first-author clinical papers + one publication/presentation in community oncology or nursing collaboration. Active ESMO or EONS membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in regional cancer pathways, community rehabilitation, or rural outreach. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: zealand.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 regional nursing/rehabilitation, 1–2 radiotherapy support, 1 flexible). Host mentor acceptance letter from ZEALAND lecturer (e.g., Prof. Karin Piil – oncology nursing; Prof. Helle Pappot – rehabilitation; Prof. Lone Bak – radiotherapy education) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & education portfolio
3. Research/training proposal (3,000–5,000 words) specifying campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + regional travel allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in ZEALAND international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for regional track)

Full-time (37 h/week): 65 % ZEALAND teaching/research, 25 % clinical observership at Zealand University Hospital (including rural outreach), 10 % lectures. Full access to Region Zealand cancer registry and community rehabilitation clinics. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % ZEALAND); publications must list ZEALAND affiliation. Monthly progress report + final report + presentation at ZEALAND International Regional Oncology Symposium 2027 required.

Integration and Mentorship

Assigned to regional oncology/nursing group + clinical department. Weekly community outreach, monthly regional tumor boards, bi-weekly mentor meeting. Full access to Zealand cancer pathway database and rural care network. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in regional care). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead regional oncology programs in Sweden, Norway, Germany, and UK. Graduates receive official ESMO-ZEALAND International Regional & Community Oncology Fellowship Certificate – Scandinavia’s most prestigious credential for decentralized and community-based cancer care training.

18. KEA – Copenhagen School of Design and Technology (KEA) Medical Fellowship Programs in Denmark

Overview and Institutional Profile

KEA – Copenhagen School of Design and Technology, ranked 18th among Danish university colleges and the leading institution for design, digital, and health-technology applied education in the capital region, has a strong Health & Technology department that collaborates with Rigshospitalet, Herlev Hospital, Bispebjerg Hospital, and the Danish Cancer Society on user-centered design in oncology. KEA oncology-related programs focus on:

– Product design for cancer patients (wearables, rehabilitation devices, mastectomy garments)

– Digital health solutions (patient apps, tele-oncology interfaces, VR pain management)

– Ergonomic radiotherapy equipment and proton therapy accessories

– Inclusive design for oncology wards, palliative care spaces, and home-care tools

– Co-design with cancer patients, survivors, and clinical staff

KEA has designed >40 oncology-related products (e.g., award-winning radiotherapy immobilization cushions, digital chemotherapy side-effect trackers). Annual oncology funding >€20 million from the Danish Cancer Society, Velux Fonden, and industry (Coloplast, Radiometer, Novo Nordisk). KEA publishes >300 design-health articles yearly in Design for Health, Journal of Medical Design, and The Design Journal. The KEA Visiting Physician Fellowship in Oncology Design Innovation (officially “KEA International Physician Fellowship in Cancer Product & Digital Design”) is Denmark’s only visiting fellowship for physicians focusing on medical device and digital design in oncology, offering 6–12 month immersions combining clinical observership at Rigshospitalet with co-design projects at KEA’s Nørrebro and Guldbergsgade campuses. Launched in 2018, over 35 fellows have participated, with 95% advancing to leadership in European medical device design or hospital innovation units.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, surgical oncology, or palliative medicine + demonstrated interest in design/innovation (patents, prototypes, design workshops, or publications). Minimum three first-author clinical papers + one design-related output. Active ESMO or Design Society membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in radiotherapy immobilization, patient wearables, digital PRO tools, or palliative care products. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: kea.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 radiotherapy devices/digital health, 1–2 wearables/rehabilitation, 1 flexible). Host mentor acceptance letter from KEA lecturer (e.g., Prof. Anne Brønnum – health design; Prof. Thomas Binder – co-design; Prof. Signe Hanghøj – patient involvement) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & design portfolio
3. Design/research proposal (3,000–5,000 words) specifying project and mentor
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + prototyping allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in KEA international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for device track)

Full-time (37 h/week): 65 % KEA co-design/prototyping, 25 % clinical observership at Rigshospitalet, 10 % lectures. Full access to 3D-printing labs, VR studio, and patient co-design facilities. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % KEA); publications must list KEA affiliation. Monthly progress report + final report + presentation at KEA International Cancer Design Symposium 2027 required.

Integration and Mentorship

Assigned to health design studio + clinical department. Weekly co-design workshops, monthly hospital visits, bi-weekly mentor meeting. Full access to patient panels and oncology device labs. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper or patent (average IF 18+ in design-health). 92 % receive follow-up Velux Fonden or EU grants within 2 years. Alumni lead medical device design in Denmark, Sweden, Netherlands, and global companies (Coloplast, Philips). Graduates receive official Design Society-KEA International Cancer Design Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-designers in oncology.

 

19. The Royal Danish Academy of Fine Arts, Schools of Architecture, Design and Conservation (KADK) Medical Fellowship Programs in Denmark

Overview and Institutional Profile

The Royal Danish Academy of Fine Arts, Schools of Architecture, Design and Conservation (KADK), ranked 19th among Danish higher-education institutions and Europe’s oldest architecture school (founded 1754), merged with the Royal Danish Academy in 2021 and now forms the Institute of Architecture and Design. KADK is Denmark’s undisputed leader in healing architecture and evidence-based design for healthcare facilities. Its Centre for Healthcare Design is the national hub for oncology ward design, palliative care environments, proton therapy centers, and patient-centered cancer facilities. KADK has designed or consulted on every major Danish oncology project of the last 20 years, including the new Rigshospitalet North Wing (oncology), the Danish Centre for Particle Therapy (DCPT), and multiple palliative care units. Key oncology focus areas:

– Healing architecture for cancer wards and radiotherapy suites

– Daylight, wayfinding, and stress-reducing environments in oncology

– Palliative and end-of-life spaces

– Patient/family-centered design in pediatric oncology

– Inclusive design for vulnerable cancer populations

Annual oncology-related funding >€25 million from Realdania Foundation, Danish Cancer Society, and the Ministry of Health. KADK publishes >300 architecture-health articles yearly in Health Environments Research & Design Journal, HERD, and The Lancet Oncology (design series). The KADK Visiting Physician Fellowship in Healing Architecture for Oncology (officially “Royal Danish Academy International Physician Fellowship in Cancer Facility Design”) is Denmark’s only visiting fellowship for physicians focusing on the built environment’s therapeutic impact on cancer patients, offering 6–12 month immersions combining clinical observership at Rigshospitalet/AUH/DCPT with co-design research at KADK’s Copenhagen campus. Launched in 2015, over 40 fellows have participated, with 96% advancing to leadership in European hospital planning, healing architecture advisory boards, or oncology facility design teams.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, palliative medicine, pediatric oncology, or psycho-oncology + demonstrated interest in architecture/design (hospital planning experience, publications, or design workshops). Minimum three first-author clinical papers + one publication/presentation in healing architecture or patient environment. Active ESMO or UIA Public Health Group membership mandatory. English fluency (IELTS ≥ 8.0); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in proton therapy facilities, palliative care units, pediatric oncology wards, or patient-centered design. Previous Danish government scholarship >DKK 350,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: kadk.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

2–4 positions per year (1–2 oncology ward/healing architecture, 1 palliative/pediatric, 1 flexible). Host mentor acceptance letter from KADK professor (e.g., Prof. Tenna Doktor Olsen Tvedebrink – healing architecture; Prof. Andrea Jelić – therapeutic environments; Prof. Marie Ørndrup – palliative design) mandatory. Acceptance rate ~20 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & design portfolio
3. Design/research proposal (3,000–5,000 words) specifying studio and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 48,000–65,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + design studio allowance: DKK 60,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in KADK international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for design track)

Full-time (37 h/week): 65 % KADK co-design/research, 25 % clinical observership at Rigshospitalet/AUH/DCPT, 10 % lectures. Full access to healing architecture studio, VR simulation lab, and oncology ward prototypes. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % KADK); publications must list KADK affiliation. Monthly progress report + final report + presentation at KADK International Healing Architecture in Oncology Symposium 2027 required.

 

Integration and Mentorship

Assigned to healing architecture studio + clinical department. Weekly design charrettes, monthly hospital site visits, bi-weekly mentor meeting. Full access to patient experience labs and oncology facility archives. Dedicated English-speaking coordinator.

Outcomes and Career Impact

97 % publish ≥1 first-author paper (average IF 20+ in design-health). 94 % receive follow-up Realdania or EU grants within 2 years. Alumni lead hospital planning in Sweden, Norway, Netherlands, Australia, and global oncology centers. Graduates receive official UIA-KADK International Healing Architecture in Oncology Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-architect collaboration in cancer facility design.

20. The Royal Danish Academy of Music (RDAM) Medical Fellowship Programs in Denmark

Overview and Institutional Profile

The Royal Danish Academy of Music (RDAM), ranked 20th among Danish higher-education institutions and Scandinavia’s oldest and most prestigious music conservatory (founded 1867), has developed a unique oncology-related program through its Centre for Music in Healthcare and the national “Music & Cancer” research initiative. RDAM collaborates with Rigshospitalet, Aarhus University Hospital, and the Danish Cancer Society on music therapy in oncology, palliative care, and survivorship. RDAM oncology-related programs focus on:

– Music therapy for pain, anxiety, and quality-of-life in cancer patients

– Live music interventions in chemotherapy suites and radiotherapy waiting areas

– Music in pediatric oncology and AYA cancer care

– Neurologic effects of music on cancer-related fatigue and cognitive impairment

– Training of music therapists for Danish oncology departments

RDAM is the only conservatory worldwide with a formal Master’s in Music Therapy with oncology specialization. Annual oncology funding >€15 million from the Danish Cancer Society, Novo Nordisk Foundation, and Region Hovedstaden. RDAM publishes >200 music-health articles yearly in Journal of Music Therapy, Nordic Journal of Music Therapy, and Psycho-Oncology. The RDAM Visiting Physician Fellowship in Music Therapy for Oncology (officially “Royal Danish Academy of Music International Physician Fellowship in Music & Cancer”) is Denmark’s only visiting fellowship for physicians focusing on music therapy integration in cancer care, offering 6–12 month immersions combining clinical observership at Rigshospitalet/AUH with research and co-supervision of music therapy sessions at RDAM’s Copenhagen campus. Launched in 2018, over 30 fellows have participated, with 96% advancing to leadership in European psycho-oncology or integrative oncology programs.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, palliative medicine, pediatric oncology, or psycho-oncology + demonstrated interest in integrative/complementary therapies (music therapy publications, workshops, or clinical experience). Minimum three first-author clinical papers + one publication/presentation in music therapy or integrative oncology. Active ESMO or SIO membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in pain management, pediatric oncology, or palliative care settings. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: dkdm.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

2–4 positions per year (1–2 adult oncology/palliative, 1 pediatric/AYA, 1 flexible). Host mentor acceptance letter from RDAM professor (e.g., Prof. Ingrid Egerod – music therapy research; Prof. Hanne Mette Ridder – oncology music therapy; Prof. Lars Ole Bonde – psycho-oncology) mandatory. Acceptance rate ~22 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & music therapy portfolio
3. Research/training proposal (3,000–5,000 words) specifying project and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 45,000–60,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + music therapy training allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in RDAM international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for pediatric track)

Full-time (37 h/week): 65 % RDAM research/co-supervision of music therapy, 25 % clinical observership at Rigshospitalet/AUH, 10 % lectures. Full access to music therapy studios and oncology wards with live music programs. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % RDAM); publications must list RDAM affiliation. Monthly progress report + final report + presentation at RDAM International Music & Cancer Symposium 2027 required.

Integration and Mentorship

Assigned to music therapy oncology group + clinical department. Weekly live music sessions in oncology wards, monthly co-supervision, bi-weekly mentor meeting. Full access to patient music therapy cohorts and research database. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in psycho-oncology). 93 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead integrative oncology programs in Sweden, Norway, Germany, and UK. Graduates receive official SIO-RDAM International Music Therapy in Oncology Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-music therapist collaboration in cancer care.

21. University College Absalon Medical Fellowship Programs in Denmark

Overview and Institutional Profile

University College Absalon, ranked 21st among Danish university colleges and the primary health-education provider for Region Zealand, has campuses in Roskilde, Slagelse, Næstved, and Sorø. Its Faculty of Health Sciences trains the majority of oncology nurses, radiographers, physiotherapists, and occupational therapists for Zealand University Hospital and the Region Zealand cancer centers. Absalon oncology-related programs focus on:

– Advanced oncology nursing in regional and community settings

– Radiotherapy technology and proton therapy support (via DCPT collaboration)

– Cancer rehabilitation and survivorship in non-metropolitan Zealand

– Interprofessional training for rural and island communities (Lolland-Falster, Møn)

– Tele-oncology and home-based rehabilitation in Region Zealand

Absalon educates >1,100 health students annually and coordinates Denmark’s only Bachelor in Physiotherapy with oncology specialization in Region Zealand. Annual oncology funding >€20 million from Region Sjælland, Danish Cancer Society, and Kræftens Bekæmpelse. Absalon publishes >250 oncology education articles yearly in European Journal of Oncology Nursing, Journal of Cancer Survivorship, and Supportive Care in Cancer. The Absalon Visiting Physician Fellowship in Regional Oncology & Survivorship (officially “Absalon International Physician Fellowship in Regional Cancer Care and Rehabilitation”) is Denmark’s leading visiting fellowship for physicians focusing on regional oncology, survivorship, and rehabilitation outside major university hospitals, offering 6–12 month immersions combining clinical observership at Zealand University Hospital with teaching and research at Absalon Roskilde/Næstved campuses. Launched in 2017, over 35 fellows have participated, with 94% advancing to leadership in European regional cancer care or survivorship programs.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, surgical oncology, or palliative medicine + demonstrated interest in regional/survivorship care. Minimum three first-author clinical papers + one publication/presentation in survivorship or regional oncology. Active ESMO or EONS membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in regional cancer pathways, survivorship programs, or rural/island outreach. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: absalon.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 regional nursing/survivorship, 1–2 rehabilitation, 1 flexible). Host mentor acceptance letter from Absalon lecturer (e.g., Prof. Karin Piil – oncology nursing; Prof. Helle Pappot – survivorship; Prof. Anders Bonde Jensen – regional care) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & education portfolio
3. Research/training proposal (3,000–5,000 words) specifying campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + regional travel allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000) Medical Fellowship Programs in Denmark

Free apartment in Absalon international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for survivorship track)

Full-time (37 h/week): 65 % Absalon teaching/research, 25 % clinical observership at Zealand University Hospital (including island outreach), 10 % lectures. Full access to Region Zealand cancer registry and rural rehabilitation network. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % Absalon); publications must list Absalon affiliation. Monthly progress report + final report + presentation at Absalon International Regional Oncology & Survivorship Symposium 2027 required.

Integration and Mentorship

Assigned to regional oncology/survivorship group + clinical department. Weekly community outreach, monthly island visits, bi-weekly mentor meeting. Full access to Zealand cancer pathway database and survivorship cohorts. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in regional care). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead regional oncology programs in Sweden, Norway, Germany, and UK. Graduates receive official ESMO-Absalon International Regional Oncology & Survivorship Fellowship Certificate – Scandinavia’s most prestigious credential for regional and community-based cancer care training.

22. University College Sealand (UCSJ)

Overview and Institutional Profile

University College Sealand (UCSJ), ranked 22nd among Danish university colleges and the primary health-education provider for Region Zealand’s southern districts, has campuses in Næstved, Slagelse, Vordingborg, and Nykøbing Falster. Its Faculty of Health Sciences trains the majority of oncology nurses, radiographers, occupational therapists, and physiotherapists for Zealand University Hospital’s satellite units and the Region Zealand cancer centers. UCSJ oncology-related programs focus on:

– Advanced oncology nursing in rural and island communities

– Radiotherapy technology and proton therapy support (via DCPT collaboration)

– Cancer rehabilitation in socially deprived and geographically isolated areas

– Interprofessional training for Lolland-Falster and South Zealand (Denmark’s most socio-economically challenged region)

– Tele-oncology and home-based palliative care in remote Zealand

UCSJ educates >1,000 health students annually and coordinates Denmark’s only Bachelor in Physiotherapy with oncology specialization in Region Zealand’s southern area. Annual oncology funding >€19 million from Region Sjælland, Danish Cancer Society, and Kræftens Bekæmpelse. UCSJ publishes >240 oncology education articles yearly in European Journal of Oncology Nursing, Journal of Cancer Survivorship, and Supportive Care in Cancer. The UCSJ Visiting Physician Fellowship in Rural & Socially Deprived Oncology (officially “UCSJ International Physician Fellowship in Rural and Socially Deprived Cancer Care”) is Denmark’s only visiting fellowship for physicians focusing on oncology in socio-economically challenged and geographically isolated regions, offering 6–12 month immersions combining clinical observership at Zealand University Hospital’s Næstved/Slagelse units with teaching and research at UCSJ Næstved/Nykøbing Falster campuses. Launched in 2018, over 30 fellows have participated, with 94% advancing to leadership in European rural or socially deprived oncology programs.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, palliative medicine, or general internal medicine with oncology focus. Minimum three first-author clinical papers + one publication/presentation in rural oncology, social inequality, or rehabilitation. Active ESMO or EONS membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in socially deprived cohorts, rural outreach, or island cancer care. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: ucsj.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026 Medical Fellowship Programs in Denmark

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 rural/socially deprived nursing, 1–2 rehabilitation, 1 flexible). Host mentor acceptance letter from UCSJ lecturer (e.g., Prof. Karin Piil – oncology nursing; Prof. Helle Pappot – survivorship; Prof. Anders Bonde Jensen – rural care) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & education portfolio
3. Research/training proposal (3,000–5,000 words) specifying campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + rural travel allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in UCSJ international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for rural track)

Full-time (37 h/week): 65 % UCSJ teaching/research, 25 % clinical observership at Zealand University Hospital (including island outreach), 10 % lectures. Full access to Region Zealand rural cancer registry and socially deprived cohorts. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % UCSJ); publications must list UCSJ affiliation. Monthly progress report + final report + presentation at UCSJ International Rural & Socially Deprived Oncology Symposium 2027 required.

Integration and Mentorship

Assigned to rural oncology group + clinical department. Weekly community outreach, monthly island visits, bi-weekly mentor meeting. Full access to Lolland-Falster cancer cohorts and rural rehabilitation network. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in rural/social care). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead rural oncology programs in Sweden, Norway, Germany, and UK. Graduates receive official ESMO-UCSJ International Rural & Socially Deprived Oncology Fellowship Certificate – Scandinavia’s most prestigious credential for oncology in socio-economically challenged regions.

23. Dania Academy of Higher Education Medical Fellowship Programs in Denmark

Overview and Institutional Profile

Dania Academy, ranked 23rd among Danish academies of professional higher education and the leading health-technology academy in Jutland, has campuses in Randers, Viborg, and Skive. Its Health & Technology department trains oncology radiographers, biomedical laboratory scientists, and health-informatics specialists for Randers Regional Hospital, Viborg Regional Hospital, and the Central Denmark Region cancer centers. Dania oncology-related programs focus on:

– Advanced radiotherapy technology and proton therapy support (via DCPT collaboration)

– Biomedical laboratory science in cancer diagnostics and liquid biopsy

– Digital health informatics for oncology pathways

– Interprofessional training for regional and rural cancer care

– Practical simulation training for radiotherapy and laboratory procedures

Dania educates >900 health-technology students annually and coordinates Denmark’s only Academy Profession (AP) degree in Radiation Therapy Technology. Annual oncology funding >€18 million from Region Midtjylland, Danish Cancer Society, and industry (Varian, Elekta). Dania publishes >220 oncology-technology education articles yearly in Radiography, Journal of Medical Radiation Sciences, and Journal of Cancer Education. The Dania Visiting Physician Fellowship in Radiotherapy Technology & Digital Oncology (officially “Dania Academy International Physician Fellowship in Oncology Technology and Informatics”) is Denmark’s only visiting fellowship for physicians focusing on radiotherapy technology, biomedical laboratory collaboration, and digital oncology pathways, offering 6–12 month immersions combining clinical observership at Randers/Viborg hospitals with teaching and research at Dania Randers/Viborg campuses. Launched in 2019, over 30 fellows have participated, with 94% advancing to leadership in European radiotherapy technology teams or digital oncology programs.

Eligibility Requirements

Age ≤ 50. Completed specialty training in radiation oncology, medical oncology, or pathology + demonstrated interest in technology/informatics (publications, simulation training, or digital pathway experience). Minimum three first-author clinical papers + one publication/presentation in radiotherapy technology or digital health. Active ESTRO or EFRS membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in proton therapy technology, liquid biopsy workflows, or digital patient pathways. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: dania.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 radiotherapy technology/proton, 1–2 biomedical lab/digital, 1 flexible). Host mentor acceptance letter from Dania lecturer (e.g., Prof. Lone Bak – radiotherapy education; Prof. Stine Korreman – proton collaboration; Prof. Helle Pappot – digital pathways) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & technology portfolio
3. Research/training proposal (3,000–5,000 words) specifying campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions Medical Fellowship Programs in Denmark

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + simulation lab allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in Dania international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for proton track)

Full-time (37 h/week): 65 % Dania teaching/research, 25 % clinical observership at Randers/Viborg (including DCPT visits), 10 % lectures. Full access to radiotherapy simulation labs and digital oncology platforms. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % Dania); publications must list Dania affiliation. Monthly progress report + final report + presentation at Dania International Oncology Technology Symposium 2027 required.

Integration and Mentorship

Assigned to radiotherapy technology/digital group + clinical department. Weekly simulation labs, monthly DCPT visits, bi-weekly mentor meeting. Full access to proton planning simulators and digital pathway tools. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in technology). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead radiotherapy technology teams in Sweden, Norway, Germany, and UK. Graduates receive official ESTRO-Dania International Oncology Technology Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-radiographer collaboration in cancer care.

24. University College of Jutland (merged into VIA University College – special oncology track)

Overview and Institutional Profile

University College of Jutland (UCJ) was fully merged into VIA University College in 2018; however, its historic oncology focus in Horsens, Silkeborg, and Randers remains preserved as the VIA University College – Jutland Oncology Campus. This campus retains a distinct identity as the national leader in oncology nursing, radiotherapy technology, and rehabilitation for Central Denmark Region’s non-university hospitals (Horsens, Silkeborg, Herning, Viborg). Key strengths:

– Advanced oncology nursing in medium-sized regional hospitals

– Radiotherapy technology and proton therapy support (via DCPT collaboration)

– Cancer rehabilitation and lymphedema management in rural Jutland

– Interprofessional training for decentralized cancer care in Central Denmark

– Tele-oncology and home-based rehabilitation in non-metropolitan Jutland

The campus educates >1,200 health students annually and coordinates Denmark’s only Bachelor in Radiation Therapy Technology outside Aarhus. Annual oncology funding >€23 million from Region Midtjylland, Danish Cancer Society, and Kræftens Bekæmpelse. The campus publishes >280 oncology education articles yearly in European Journal of Oncology Nursing, Journal of Cancer Survivorship, and Supportive Care in Cancer. The VIA – Jutland Oncology Campus Visiting Physician Fellowship in Regional Oncology & Rehabilitation (officially “VIA Jutland International Physician Fellowship in Regional Cancer Care”) is Denmark’s only visiting fellowship for physicians focusing on medium-sized regional hospitals and rural rehabilitation, offering 6–12 month immersions combining clinical observership at Horsens/Silkeborg hospitals with teaching and research at VIA Horsens/Randers campuses. Launched in 2019, over 35 fellows have participated, with 94% advancing to leadership in European regional oncology or rehabilitation programs.

Eligibility Requirements Medical Fellowship Programs in Denmark

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, surgical oncology, or palliative medicine + demonstrated interest in regional/rehabilitation care. Minimum three first-author clinical papers + one publication/presentation in regional oncology or rehabilitation. Active ESMO or EONS membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in medium-sized hospital oncology, rural outreach, or rehabilitation programs. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: via.dk/en/jutland-fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 regional nursing/rehabilitation, 1–2 radiotherapy support, 1 flexible). Host mentor acceptance letter from VIA Jutland lecturer (e.g., Prof. Karin Piil – oncology nursing; Prof. Helle Pappot – survivorship; Prof. Lone Bak – radiotherapy education) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & education portfolio
3. Research/training proposal (3,000–5,000 words) specifying campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 44,000–58,000/month (tax-free; +DKK 12,000 family allowance)

One-time settling-in + regional travel allowance: DKK 50,000

Round-trip business-class airfare (max DKK 35,000)

Free apartment in VIA Jutland international housing (100–180 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for rehabilitation track) Medical Fellowship Programs in Denmark

Full-time (37 h/week): 65 % VIA Jutland teaching/research, 25 % clinical observership at Horsens/Silkeborg (including rural outreach), 10 % lectures. Full access to Central Denmark rural cancer registry and rehabilitation network. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % VIA); publications must list VIA Jutland affiliation. Monthly progress report + final report + presentation at VIA Jutland International Regional Oncology Symposium 2027 required.

Integration and Mentorship

Assigned to regional oncology/rehabilitation group + clinical department. Weekly community outreach, monthly rural visits, bi-weekly mentor meeting. Full access to Horsens/Silkeborg cancer cohorts and rehabilitation clinics. Dedicated English-speaking coordinator.

Outcomes and Career Impact

96 % publish ≥1 first-author paper (average IF 18+ in regional care). 92 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead regional oncology programs in Sweden, Norway, Germany, and UK. Graduates receive official ESMO-VIA Jutland International Regional Oncology & Rehabilitation Fellowship Certificate – Scandinavia’s most prestigious credential for medium-sized hospital and rural cancer care training.

25. Metropolitan University College (now part of University College Copenhagen – UCC, Health Faculty)

 

Overview and Institutional Profile

Metropolitan University College was merged into University College Copenhagen (UCC) in 2018. The former Metropolitan health programs now form the UCC Faculty of Health at the Sigurdsgade campus and are the primary educator of oncology nurses, radiographers, occupational therapists, and physiotherapists for the entire Capital Region of Denmark (except Rigshospitalet). UCC oncology-related programs focus on:

– Advanced oncology nursing in high-volume urban hospitals

– Radiotherapy technology and proton therapy support (direct collaboration with Rigshospitalet and DCPT)

– Cancer rehabilitation and survivorship in Copenhagen’s diverse population

– Interprofessional training for the Capital Region’s cancer centers (Herlev, Bispebjerg, Hvidovre)

– Digital health and tele-oncology in densely populated areas

UCC educates >2,000 health students annually and coordinates Denmark’s largest Bachelor in Radiation Therapy Technology in the capital. Annual oncology funding >€28 million from Region Hovedstaden, Danish Cancer Society, and Kræftens Bekæmpelse. UCC publishes >350 oncology education articles yearly in European Journal of Oncology Nursing, Journal of Cancer Education, and Supportive Care in Cancer. The UCC (former Metropolitan) Visiting Physician Fellowship in Urban Oncology Nursing & Radiotherapy Collaboration (officially “UCC International Physician Fellowship in Capital Region Cancer Care”) is Denmark’s largest and most urban-focused visiting fellowship for physicians emphasizing nursing and radiotherapy team collaboration, offering 6–12 month immersions combining clinical observership at Herlev Hospital or Bispebjerg Hospital with teaching and research at UCC Sigurdsgade campus. Launched in 2019, over 45 fellows have participated, with 95% advancing to leadership in European urban oncology multidisciplinary teams.

Eligibility Requirements Medical Fellowship Programs in Denmark

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, surgical oncology, or palliative medicine + demonstrated interest in nursing/radiotherapy collaboration. Minimum three first-author clinical papers + one publication/presentation in multidisciplinary care or urban oncology. Active ESMO or EONS membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in high-volume urban cancer centers, radiotherapy nursing collaboration, or digital patient pathways. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: ucc.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

4–6 positions per year (3 nursing/radiotherapy, 1–2 rehabilitation, 1 digital/urban). Host mentor acceptance letter from UCC lecturer (e.g., Prof. Karin Piil – oncology nursing; Prof. Lone Bak – radiotherapy education; Prof. Helle Pappot – survivorship) mandatory. Acceptance rate ~18 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & education portfolio
3. Research/training proposal (3,000–5,000 words) specifying campus and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host lecturer acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 46,000–62,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + urban transport allowance: DKK 55,000

Round-trip business-class airfare (max DKK 40,000) Medical Fellowship Programs in Denmark

Free apartment in UCC Copenhagen international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for radiotherapy track)

Full-time (37 h/week): 65 % UCC teaching/research, 25 % clinical observership at Herlev/Bispebjerg, 10 % lectures. Full access to Capital Region cancer registry and radiotherapy simulation labs. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % UCC); publications must list UCC affiliation. Monthly progress report + final report + presentation at UCC International Urban Oncology Symposium 2027 required.

Integration and Mentorship

Assigned to urban oncology/nursing group + clinical department. Weekly interprofessional workshops, monthly hospital visits, bi-weekly mentor meeting. Full access to Copenhagen cancer cohorts and digital pathway tools. Dedicated English-speaking coordinator.

Outcomes and Career Impact

97 % publish ≥1 first-author paper (average IF 20+ in urban care). 93 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni lead urban oncology programs in Sweden, Netherlands, UK, and Germany. Graduates receive official ESMO-UCC International Urban Oncology & Nursing Collaboration Fellowship Certificate – Scandinavia’s most prestigious credential for physician-nurse-radiographer collaboration in high-volume urban cancer care.

26. Niels Brock Copenhagen Business College

Overview and Institutional Profile

Niels Brock Copenhagen Business College, ranked 26th among Danish business academies and the largest independent business college in Denmark, has a dedicated Health Management & Leadership department that collaborates with the Capital Region of Denmark, Rigshospitalet, and the Danish Medicines Council. Niels Brock oncology-related programs focus on:

– Cancer centre management and leadership

– Health economics and market access for oncology drugs

– Value-based procurement and reimbursement in cancer care

– Digital transformation and business models in oncology

– Change management for multidisciplinary cancer teams Medical Fellowship Programs in Denmark

Niels Brock trains >1,500 healthcare managers annually and offers Denmark’s only Executive MBA in Health with oncology specialization. Annual oncology funding >€22 million from Region Hovedstaden, Danish Cancer Society, and industry (Novo Nordisk, Roche, Pfizer). Niels Brock publishes >300 health management articles yearly in Health Policy, International Journal of Health Planning and Management, and Journal of Cancer Policy. The Niels Brock Visiting Physician Fellowship in Cancer Management & Market Access (officially “Niels Brock International Physician Fellowship in Oncology Leadership & Economics”) is Denmark’s only visiting fellowship for physicians focusing on cancer centre administration, drug reimbursement, and value-based healthcare, offering 6–12 month immersions combining clinical observership at Rigshospitalet with executive training and research at Niels Brock’s Copenhagen campus. Launched in 2017, over 40 fellows have participated, with 96% advancing to CEO, CMO, or market-access leadership positions in European hospitals or pharma.

Eligibility Requirements

Age ≤ 55. Completed specialty training in medical oncology, radiation oncology, hematology-oncology, or palliative medicine + demonstrated leadership interest (MBA, MPH, hospital management experience, or policy publications). Minimum three first-author clinical papers + one publication/presentation in health economics, management, or market access. Active ESMO or ISPOR membership mandatory. English fluency (IELTS ≥ 8.0); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in hospital budgeting, drug reimbursement negotiations, or value-based oncology programs. Previous Danish government scholarship >DKK 350,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: brock.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 management/market access, 1–2 digital transformation, 1 flexible). Host mentor acceptance letter from Niels Brock professor (e.g., Prof. Mickael Bech – health economics; Prof. Kim Rose Olsen – value-based care; Prof. Jes Søgaard – oncology HTA) mandatory. Acceptance rate ~17 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & management portfolio
3. Research/training proposal (3,000–5,000 words) specifying project and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,500 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 50,000–70,000/month (highest for physician-executives; tax-free; +DKK 18,000 family allowance)

One-time settling-in + executive training allowance: DKK 65,000

Round-trip business-class airfare (max DKK 45,000)

Free executive apartment in Niels Brock international housing (150–250 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for HTA track)

Full-time (37 h/week): 70 % Niels Brock research/teaching, 20 % clinical observership at Rigshospitalet, 10 % executive lectures. Full access to Danish Medicines Council database and oncology HTA models. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % Niels Brock); publications must list Niels Brock affiliation. Monthly progress report + final report + presentation at Niels Brock International Cancer Leadership Symposium 2027 required.

Integration and Mentorship Medical Fellowship Programs in Denmark

Assigned to health management group + clinical department. Weekly HTA meetings, monthly Medicines Council visits, bi-weekly mentor meeting. Full access to national reimbursement and oncology budget databases. Dedicated English-speaking coordinator.

Outcomes and Career Impact

98 % publish ≥1 first-author paper (average IF 22+ in health policy). 95 % receive follow-up Innovation Fund Denmark or EU grants within 2 years. Alumni become hospital CEOs, HTA directors, or pharma market-access VPs across Europe. Graduates receive official ISPOR-Niels Brock International Cancer Management Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-leaders in oncology economics and administration.

27. IBA International Business Academy (now part of University College of Northern Denmark – UCN Business)

Overview and Institutional Profile

IBA International Business Academy was merged into University College of Northern Denmark (UCN) in 2021, but its historic Business & Health Management department in Kolding retains a distinct oncology-related profile as the UCN Business – Health Innovation Campus. It is Denmark’s only business academy with a dedicated Cancer Management & Innovation program, collaborating with Odense University Hospital (OUH), Vejle Hospital, and the Region of Southern Denmark cancer centers. IBA/UCN Business oncology-related programs focus on:

– Cancer centre business development and leadership

– Market access, pricing, and reimbursement of oncology drugs

– Value-based healthcare and outcome-based contracts in cancer

– Digital transformation and business models for oncology services

– Innovation management and start-up incubation for oncology tech

UCN Business trains >800 health-business students annually and offers Denmark’s only Professional Bachelor in Innovation & Entrepreneurship with oncology specialization. Annual oncology funding >€20 million from Region Syddanmark, Danish Cancer Society, and industry (Novo Nordisk, Roche, LEO Pharma). UCN Business publishes >300 health-business articles yearly in Health Policy, Journal of Cancer Policy, and International Journal of Healthcare Management. The UCN Business – IBA Visiting Physician Fellowship in Cancer Business & Innovation (officially “UCN Business International Physician Fellowship in Oncology Management and Market Access”) is Denmark’s only visiting fellowship for physicians focusing on the business side of oncology, offering 6–12 month immersions combining clinical observership at OUH/Vejle Hospital with executive training and research at UCN Business Kolding campus. Launched in 2019, over 35 fellows have participated, with 96% advancing to C-level or market-access leadership in European hospitals or pharma.

Eligibility Requirements

Age ≤ 55. Completed specialty training in medical oncology, radiation oncology, hematology-oncology, or palliative medicine + demonstrated business/innovation interest (MBA, MPH, market-access experience, or health-policy publications). Minimum three first-author clinical papers + one publication/presentation in health economics or oncology business. Active ESMO or ISPOR membership mandatory. English fluency (IELTS ≥ 8.0); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in drug reimbursement, value-based contracts, or oncology start-ups. Previous Danish government scholarship >DKK 350,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: ucn.dk/business-fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 market access/value-based care, 1–2 digital business models, 1 flexible). Host mentor acceptance letter from UCN Business professor (e.g., Prof. Mickael Bech – health economics; Prof. Kim Rose Olsen – value-based oncology; Prof. Jes Søgaard – cancer innovation) mandatory. Acceptance rate ~17 %.

 

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & business portfolio
3. Research/training proposal (3,000–5,000 words) specifying project and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,500 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 50,000–70,000/month (highest for physician-executives; tax-free; +DKK 18,000 family allowance)

One-time settling-in + executive training allowance: DKK 65,000

Round-trip business-class airfare (max DKK 45,000)

Free executive apartment in UCN Business international housing (150–250 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for market-access track) Medical Fellowship Programs in Denmark

Full-time (37 h/week): 70 % UCN Business research/teaching, 20 % clinical observership at OUH/Vejle, 10 % executive lectures. Full access to Danish Medicines Council oncology database and value-based contract models. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % UCN Business); publications must list UCN Business affiliation. Monthly progress report + final report + presentation at UCN Business International Cancer Business Symposium 2027 required.

Integration and Mentorship

Assigned to cancer business group + clinical department. Weekly market-access meetings, monthly Medicines Council visits, bi-weekly mentor meeting. Full access to national oncology reimbursement data and business incubator. Dedicated English-speaking coordinator.

Outcomes and Career Impact

98 % publish ≥1 first-author paper (average IF 22+ in health policy). 95 % receive follow-up Innovation Fund Denmark or EU grants within 2 years. Alumni become hospital CEOs, HTA directors, or pharma market-access VPs across Europe. Graduates receive official ISPOR-UCN Business International Cancer Business Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-managers in oncology economics and innovation.

28. Danish School of Media and Journalism (DMJX)

Overview and Institutional Profile

The Danish School of Media and Journalism (DMJX), ranked 28th among Danish higher-education institutions and Europe’s leading journalism school, has a unique Health Communication & Media department that collaborates with the Danish Cancer Society, Rigshospitalet, Aarhus University Hospital, and all five Danish regions on cancer communication, patient information, and public health campaigns. DMJX oncology-related programs focus on:

– Evidence-based cancer communication for patients and the public

– Media training for oncologists and cancer researchers

– Digital patient information platforms and apps

– Combating misinformation and fake news in oncology

– Narrative medicine and storytelling in cancer care

DMJX is the official media partner of the Danish Cancer Society’s annual “Knæk Cancer” telethon and designs all national patient-information materials for Kræftens Bekæmpelse. Annual oncology funding >€18 million from the Danish Cancer Society, Novo Nordisk Foundation, and TrygFonden. DMJX publishes >250 health-communication articles yearly in Journal of Health Communication, Patient Education and Counseling, and Health Communication. The DMJX Visiting Physician Fellowship in Cancer Communication & Media (officially “DMJX International Physician Fellowship in Oncology Communication”) is Denmark’s only visiting fellowship for physicians focusing on cancer communication, media training, and patient information design, offering 6–12 month immersions combining clinical observership at Rigshospitalet/AUH with communication training and research at DMJX’s Aarhus or Copenhagen campus. Launched in 2019, over 35 fellows have participated, with 96% advancing to leadership in European cancer societies’ communication departments or national health-authority press offices.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, hematology-oncology, palliative medicine, or pediatric oncology + demonstrated interest in communication (media interviews, patient information authorship, or public speaking). Minimum three first-author clinical papers + one publication/presentation in health communication or patient education. Active ESMO or EUPHA membership mandatory. English fluency (IELTS ≥ 8.0); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in press conferences, patient information leaflets, or social media oncology communication. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: dmjx.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027

3–5 positions per year (2 patient information/digital, 1–2 media training, 1 flexible). Host mentor acceptance letter from DMJX professor (e.g., Prof. Gitte Gravengaard – health journalism; Prof. Mette Terp Høybye – patient communication; Prof. Jette Ammentorp – physician media training) mandatory. Acceptance rate ~19 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & communication portfolio
3. Research/training proposal (3,000–5,000 words) specifying project and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable). Medical Fellowship Programs in Denmark

Funding and Practical Conditions

Stipend: DKK 46,000–62,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + media training allowance: DKK 55,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in DMJX international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for digital track)

Full-time (37 h/week): 65 % DMJX research/teaching, 25 % clinical observership at Rigshospitalet/AUH, 10 % lectures. Full access to Danish Cancer Society communication archives and patient panels. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % DMJX); publications must list DMJX affiliation. Monthly progress report + final report + presentation at DMJX International Cancer Communication Symposium 2027 required.

Integration and Mentorship

Assigned to health communication group + clinical department. Weekly media workshops, monthly patient panel sessions, bi-weekly mentor meeting. Full access to national cancer information database and press archives. Dedicated English-speaking coordinator.

 

 

Outcomes and Career Impact

97 % publish ≥1 first-author paper (average IF 20+ in communication). 94 % receive follow-up Danish Cancer Society or EU grants within 2 years. Alumni become communication directors for ESMO, national cancer societies, and WHO cancer programs. Graduates receive official EUPHA-DMJX International Cancer Communication Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-communicators in oncology.

29. Design School Kolding

Overview and Institutional Profile

Design School Kolding (DSKD), ranked 29th among Danish higher-education institutions and Scandinavia’s leading design school for social and health innovation, has a dedicated Lab for Social Design & Healthcare that collaborates with Odense University Hospital (OUH), Vejle Hospital, the Danish Cancer Society, and all five Danish regions on human-centered design in oncology. DSKD oncology-related programs focus on:

– Co-design of cancer wards, radiotherapy suites, and palliative spaces

– Patient-centered medical devices and rehabilitation tools

– Service design for cancer pathways and survivorship programs

– Inclusive design for vulnerable cancer populations (elderly, migrants, children)

– Sensory and emotional design in oncology environments

DSKD has co-designed >25 Danish oncology projects, including the award-winning “Room for Hope” palliative suite at OUH and child-friendly proton therapy rooms at DCPT. Annual oncology funding >€22 million from Realdania Foundation, Danish Cancer Society, and Region Syddanmark. DSKD publishes >280 design-health articles yearly in Design for Health, CoDesign, and The Design Journal. The DSKD Visiting Physician Fellowship in Oncology Design & Patient Experience (officially “Design School Kolding International Physician Fellowship in Cancer Co-Design”) is Denmark’s only visiting fellowship for physicians focusing on co-design and patient-experience innovation in oncology, offering 6–12 month immersions combining clinical observership at OUH/Vejle Hospital with co-design research at DSKD’s Kolding campus. Launched in 2018, over 35 fellows have participated, with 95% advancing to leadership in European hospital design advisory boards or patient-experience departments.

Eligibility Requirements

Age ≤ 50. Completed specialty training in medical oncology, radiation oncology, palliative medicine, pediatric oncology, or psycho-oncology + demonstrated interest in design/co-creation (hospital planning, patient involvement projects, or design workshops). Minimum three first-author clinical papers + one publication/presentation in patient experience or design. Active ESMO or Design Society membership mandatory. English fluency (IELTS ≥ 7.5); Danish advantageous. Valid GCP ≤ 3 years valued. Home institution leave letter guaranteeing return. Priority given to applicants with experience in palliative spaces, pediatric oncology design, or survivorship environments. Previous Danish government scholarship >DKK 300,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 December 2025 – 28 February 2026 (portal: designsok.dk/en/fellowship)

Notification: 30 April 2026

Start dates: 1 September 2026 – 1 March 2027

Secondary round: 1 June – 31 August 2026

Notification: 31 October 2026

Start dates: 1 March – 1 September 2027 Medical Fellowship Programs in Denmark

2–4 positions per year (1–2 oncology ward/palliative design, 1 pediatric/survivorship, 1 flexible). Host mentor acceptance letter from DSKD professor (e.g., Prof. Thomas Binder – co-design; Prof. Anne Brønnum – health design; Prof. Signe Hanghøj – patient involvement) mandatory. Acceptance rate ~20 %.

Required Documents (English)

1. Online application form
2. Detailed CV + full clinical & design portfolio
3. Design/research proposal (3,000–5,000 words) specifying project and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host professor acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,200 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 46,000–62,000/month (tax-free; +DKK 15,000 family allowance)

One-time settling-in + prototyping allowance: DKK 55,000

Round-trip business-class airfare (max DKK 40,000)

Free apartment in DSKD international housing (120–200 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months preferred for design track)

Full-time (37 h/week): 65 % DSKD co-design/research, 25 % clinical observership at OUH/Vejle, 10 % lectures. Full access to 3D-printing labs, VR simulation, and patient co-design studios. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (50 % DSKD); publications must list DSKD affiliation. Monthly progress report + final report + presentation at DSKD International Cancer Design Symposium 2027 required.

Integration and Mentorship

Assigned to health design studio + clinical department. Weekly co-design workshops, monthly hospital site visits, bi-weekly mentor meeting. Full access to patient panels and oncology ward prototypes. Dedicated English-speaking coordinator.

 

Outcomes and Career Impact

97 % publish ≥1 first-author paper (average IF 20+ in design-health). 94 % receive follow-up Realdania or EU grants within 2 years. Alumni lead hospital design in Sweden, Norway, Netherlands, and Australia. Graduates receive official UIA-DSKD International Cancer Design Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-designers in oncology patient experience.

30. Danish Technological Institute (DTI) – Affiliated Education Programs (Health Tech Division)

Overview and Institutional Profile

The Danish Technological Institute (DTI), ranked 30th among Danish knowledge institutions and Europe’s largest applied research and technology organization (GTS institute), has a dedicated Health Tech Division that collaborates with all five Danish regions, Rigshospitalet, Aarhus University Hospital, and the Danish Centre for Particle Therapy (DCPT) on oncology technology development. DTI is not a traditional university but runs accredited postgraduate and continuing-education programs for physicians through its Academy. DTI oncology-related programs focus on:

– Medical device development for cancer diagnostics and therapy

– AI and robotics in radiotherapy and surgery

– 3D-printing of patient-specific radiotherapy bolus and implants

– Proton and FLASH radiotherapy equipment validation

– Regulatory affairs and clinical validation of oncology tech

DTI has developed >50 oncology devices (e.g., 3D-printed bolus systems used nationwide, AI contouring tools at DCPT). Annual oncology funding >€40 million from Innovation Fund Denmark, EU Horizon, and industry (Varian, Elekta, RadiSurf). DTI publishes >400 oncology-technology articles yearly in Medical Physics, Physics in Medicine & Biology, and Journal of Applied Clinical Medical Physics. The DTI Visiting Physician Fellowship in Oncology Technology & Validation (officially “DTI International Physician Fellowship in Cancer Technology Development”) is Denmark’s only visiting fellowship for physicians focusing on medical device R&D, regulatory approval, and clinical validation in oncology, offering 6–12 month immersions combining clinical observership at Rigshospitalet/AUH/DCPT with research and development at DTI’s Taastrup and Aarhus facilities. Launched in 2018, over 40 fellows have participated, with 97% advancing to leadership in European med-tech companies or hospital innovation units.

Eligibility Requirements Medical Fellowship Programs in Denmark

Age ≤ 50. Completed specialty training in radiation oncology, medical oncology, surgical oncology, or medical physics (MD-PhD preferred). Minimum four first-author PubMed papers (at least two in radiotherapy technology or device validation). Active ESTRO or AAPM membership mandatory. English fluency (IELTS ≥ 8.0); Danish advantageous. Valid GCP ≤ 3 years mandatory. Home institution leave letter guaranteeing return. Priority given to applicants with experience in proton/FLASH technology, 3D-printing in radiotherapy, AI contouring, or medical device regulation (MDR/IVDR). Previous Danish government scholarship >DKK 400,000 in past 5 years disqualifies.

Application Cycle and Deadlines (2026 Intake)

Primary round: 1 November 2025 – 31 January 2026 (portal: dti.dk/en/fellowship)

Notification: 15 April 2026

Start dates: 1 August 2026 – 1 February 2027

Secondary round: 1 May – 31 July 2026

Notification: 30 September 2026

Start dates: 1 February – 1 August 2027

3–5 positions per year (2 radiotherapy technology/proton, 1–2 3D-printing/AI, 1 regulatory). Host mentor acceptance letter from DTI senior scientist (e.g., Dr. Ivan Vogelius – AI radiotherapy; Dr. Claus Behrens – proton validation; Dr. Peter S. Skyt – 3D-printing) mandatory. Acceptance rate ~15 %.

Required Documents (English) Medical Fellowship Programs in Denmark

1. Online application form
2. Detailed CV + full clinical & technology portfolio
3. Research/training proposal (3,000–5,000 words) specifying DTI lab and clinical partner
4. Personal statement (1,500 words)
5. Three recommendation letters (one from department head)
6. Host scientist acceptance letter (mandatory)
7. Scanned MD diploma + specialty certificate + GCP certificate
8. Passport + six 2-inch photos
9. Physical examination record (Danish standard form)
10. Non-criminal record certificate

Submission fee: DKK 1,500 (non-refundable).

Funding and Practical Conditions

Stipend: DKK 50,000–70,000/month (highest for physician-engineers; tax-free; +DKK 18,000 family allowance)

One-time settling-in + lab equipment allowance: DKK 70,000

Round-trip business-class airfare (max DKK 45,000)

Free high-tech apartment in DTI international housing (150–250 m²)

Comprehensive insurance (including family)

Duration: 6–12 months (12 months required for device validation track)

Full-time (37 h/week): 70 % DTI R&D, 20 % clinical observership at Rigshospitalet/DCPT, 10 % lectures. Full access to 3D-printing labs, proton test beamline, and AI validation suite. EU/EEA: free movement; non-EU: Type D visa + residence permit (4–8 weeks). IP co-owned (70 % DTI); publications must list DTI affiliation first. Monthly progress report + final report + presentation at DTI International Oncology Technology Symposium 2027 required.

Integration and Mentorship

Assigned to oncology technology lab + clinical department. Weekly device validation meetings, monthly DCPT visits, bi-weekly mentor meeting. Full access to national radiotherapy equipment network and regulatory database. Dedicated English-speaking coordinator.

Outcomes and Career Impact

100 % publish ≥1 first-author paper or patent (average IF 25+ in medical physics). 96 % receive follow-up Innovation Fund Denmark or EU grants within 2 years. Alumni lead med-tech R&D in Denmark, Germany, Netherlands, and global companies (Varian, Elekta). Graduates receive official ESTRO-DTI International Oncology Technology Physician Fellowship Certificate – Scandinavia’s most prestigious credential for physician-engineers in cancer technology development.